AREAS OF ACTIVITY - Clinical and Veterinary Science
analysis
asthma
biology
biomarkers
brain
cancer
cardiovascular
care
cell
chronic
clinical
development
diabetes
disease
disorder
drug
epidemiology
failure
function
genetics
health
heart
human
hypertension
imaging
immune
immunology
infection
infectious
inflammation
liver
lung
mechanism
medical
medicine
metabolism
model
molecular
nursing
other
pharmacology
public
pulmonary
research
resistance
respiratory
study
therapy
translational
treatment
trial
tumor
See All
AREAS OF ACTIVITY - Clinical and Veterinary Science
-
acute
- Acute and chronic heart failure
- Acute and chronic pancreatitis
- Acute coronary syndromes
- Acute pancreatis
- Acute phase protein response in animals and their use in diagnostic analysis
- Acute phase proteins
- Acute recreational drug toxicity
- Acute respiratory distress syndrome
- Acute stroke care
- Acute treatment of stroke
- Arrhythmias and acute coronary syndromes
- Clinical and translational research in acute pancreatitis
- Description of a 4-hour therapeutic window in acute ischaemic stroke in man
- Experimental acute kidney injury
- Observational clinical trials in acute pancreatitis (APPLE, PINEAPPLE, EASY, LIFESPAN)
- Randomized interventional clinical trials in acute pancreatitis (GOULASH, PREPAST, EMILY)
-
airway
- Airway macrophage
- Airway pharmacology
- Airway smooth muscle biology in asthma
- Asbestos Exposure: Lung Function – Pathology – Small Airways Dysfunction
- Basic, translational and clinical research in chronic airway diseases (COPD, asthma)
- Genomic characterization of the airway microbiota and airway microbial communities
- Immunology of the airways.
- Innate and adaptive immunity in the airways
- Mitochondrial and oxidant airway injury by fine and ultrafine particles
- Molecular events and Interactions between immunocompetent cells, inflammatory cells, epithelial cells in allergic inflammation and airways remodelling
- Preclinical and clinical research in obstructive airway diseases (Asthma and Chronic Obstructive Pulmonary Disease)
-
analysis
- Acute phase protein response in animals and their use in diagnostic analysis
- Analysis of high-dimensional data
- Analysis of the realisation of patients' rights
- Analysis of the structures and functions of proteinases
- Biostatistics, survival analysis, meta-analysis, prognostic models
- Cloning and gene analysis of proteases, cytokines and chemokines
- Computer analysis of the cardiovascular signals
- Data analysis
- Epidemiological analysis of pancreatic diseases (AP, CP, PC, AIP)
- Food composition and analysis
- Guidance for planning and analysis of observational studies - The STRATOS initiative
- Human movement analysis
- Mass cytometry and analysis of high dimensional data
- Mental health trial design and analysis
- Metabolomics, lipidomics, microbiomics, olfactomics analyses
- Molecular genetic analysis of multifactorial diseases/traits
- Monitoring bovine mastitis by biomarker analysis
- Multiphase survey design and analysis
- Protein purification and analysis for diagnostics
- Research in clinical nursing/health care, consisting of analysis and instrumentation
- Specific protein analysis
- Structural and functional brain network analysis
- Systems medicine and network analysis
-
animal
- Acute phase protein response in animals and their use in diagnostic analysis
- Animal Models for AIDS
- Animal health
- Animal model
- Animal models
- Animal models of liver cancers and liver damage, and liver metastasis
- Biomarkers of disease of animals
- Ehrlichial and anaplasmal infections in animals and man
- Experimental animal models of infections (endocarditis, osteomyelitis)
- Investigation of newly developed kynurenine-amino-transferase (KAT) knock-out animals
- Investigation of newly synthesized kynurenic acid analogues in different animal models of neurological disorders
- Novel approaches to new compounds to be used in animal food production
- Proteins of serum, milk and other biological fluids of domestic animals
- Proteomics as applied to domestic animals
- Risk assessments evaluation to animals, humans and environment
-
antimicrobial
- Antimicrobial drug development
- Antimicrobial pharmacokinetics and pharmacodynamics
- Antimicrobial resistance
- Antimicrobial resistance
- Antimicrobial stewardship and treatment of complicated bacterial and fungal infections
- Antimicrobial therapy of invasive candidiasis, aspergillosis
- Economical models on antimicrobial resistance
- In vitro activity of newer antimicrobial agents including interactions with other classes of antibiotics
- One health antimicrobial resistance
- PK/PDs of newer antimicrobial agents
- Resistant mechanism of antimicrobial agents
-
asthma
- Airway smooth muscle biology in asthma
- Allergic asthma
- Allergic asthma
- Asthma
- Asthma
- Asthma Outbreaks by Soybean Dust Inhalation: Diagnosis – Pathognesis – Prevention
- Asthma and allergies
- Asthma epidemiology
- Biologics in Severe Asthma Treatment
- Clinical and molecular phenotyping of asthma
- Corticosteroid insensitivity in severe asthma
- Focus on asthma phenotypes, biomarkers and novel treatments including applications of biologics
- Immunopathology of atopic and nonatopic asthma
- Investigation of the pathophysiology and management of both asthma and COPD
- Large-scale genetic studies of asthma
- Mechanisms and treatment of severe and difficult-to-treat asthma
- Oxidative metabolism in asthma and COPD
- Paediatrics with special interest in childhood asthma and childhood allergies
- Precision medicine for severe asthma
- Respiratory Medicine: specifically asthma and chronic obstructive pulmonary disease
- Role of antigen-presenting in asthma
-
biology
- Airway smooth muscle biology in asthma
- Biology
- Biology of eosinophils and neutrophils
- Biology of the adipose tissue
- Bone and cartilage biology
- Cancer biology
- Cell biology
- Circadian biology
- Complement Biology
- Computational biology
- Endometrial biology
- Evolutionary biology
- Host-pathogen interaction and macrophage biology
- Keratinocyte/epithelial cell biology
- Liver cell biology
- Lung cellular and molecular biology
- Lymphoma biology
- Lysosomal biology
- Macrophage biology
- Mathematical biology
- Mitochondrial biology
- Molecular Biology technology
- Molecular biology
- Molecular biology
- Molecular biology in cardiology
- Molecular biology of brain tumors
- Natural killer (NK) cell biology
- Neutrophil biology
- Pathophysiology, cell biology and genetics of pancreatic disorders
- Stem cell biology
- Stress hormone biology
- Synthetic Biology
- System biology - omics, statistical tool coding and development
- System biology based molecular characterization of atherosclerotic plaques and above cohorts.
- Systems biology
- Tumor biology
- Tumour-associated macrophage biology
- Vascular biology
- Vascular biology
- Vascular biology and medicine
-
biomarkers
- Atherosclerosis related disease biomarkers discovery, risk prediction and clinical testing
- Biomarkers
- Biomarkers
- Biomarkers and adjunctive immunotherapy of infection
- Biomarkers for early detection and treatment of GI cancer.
- Biomarkers for transporter-mediated drug-drug interactions
- Biomarkers of disease of animals
- Biomarkers of inflammation
- Biomarkers of response and toxicity to improve therapeutic ratio for liver cancer treatments
- Biomarkers of sepsis and pneumonia
- Cancer biomarkers
- Cancer detection biomarkers Oesophageal cancer
- Development of biomarkers and technologies for the non-invasive evaluation of disease progression in chronic liver diseases
- Early biomarkers of primary liver cancerHepatitis C and B
- Focus on asthma phenotypes, biomarkers and novel treatments including applications of biologics
- Inflammatory biomarkers in breath
- Molecular biomarkers of migraine (CGRP, PACAP, kynurenines etc.)
- Molecular biomarkers of multiple sclerosis (catecohlamines, kynurenines, neurofilament etc.)
- Multivariate components biomarkers
- Pharmacodynamic biomarkers
- Predictive and prognostic biomarkers for personalized medicine
- Predictive biomarkers for targeted therapies in solid tumours
- Prognostic and predictive biomarkers
- Telomeres length, chronic diseases and aging. Focus on biomarkers and modulation of telomerase
-
brain
- Brain
- Brain Imaging
- Brain as a metabolic organ
- Brain bank
- Brain banking
- Brain chemical sensors
- Brain developent
- Brain edema
- Brain function and brain health
- Brain plasticity
- Brain tumor and brain function protection
- Chemotherapy of brain tumors
- Consequences of hypertension on the brain
- Deep brain stimulation in mental disorders
- Dilated perivascular spaces in the brain
- Functional and structural architecture of the human brain in health and disease
- Human brain
- Human brain changes throughout the lifespan using magnetic resonance imaging and fetal ultrasound
- Intraoperative imaging of the brain
- Metastatic brain tumors
- Molecular biology of brain tumors
- National Brain Tumor Registry of China
- Plasticity of the human brain
- Positron emission tomography of the human brain (PET)
- Prevention of epilepsy after brain injury
- Recovery from brain damage and rehabilitation
- Sexual differentiation of the brain
- Structural and functional brain network analysis
- The blood-brain barrier in the healthy and diseased brain
- Vascular brain lesions on MRI
-
cancer
- Advances in lung cancer screening
- Advances in radiotherapy of lung cancer
- Animal models of liver cancers and liver damage, and liver metastasis
- Biomarkers for early detection and treatment of GI cancer.
- Biomarkers of response and toxicity to improve therapeutic ratio for liver cancer treatments
- Breast cancer
- Breast cancer proteomics
- Cancer
- Cancer
- Cancer & work
- Cancer antigen discovery and cellular/humoral immune recognition
- Cancer biology
- Cancer biomarkers
- Cancer clinical trials
- Cancer detection biomarkers Oesophageal cancer
- Cancer drug development
- Cancer drug resistance
- Cancer epidemiology
- Cancer epidemiology
- Cancer epidemiology and cancer prevention
- Cancer follow-up
- Cancer genetics
- Cancer genomics
- Cancer immunology
- Cancer immunotherapy
- Cancer immunotherapy and cancer vaccine development
- Cancer metabolism
- Cancer nanomedicine (mainly peadiaric cancer)
- Cancer prevention
- Cancer research
- Cancer research
- Cancer research (primarily psychosocial, symptom, secondary prevention)
- Cancer risk in patients with pancreatitis, cystic fibrosis, end-stage renal disease, hepatitic C virus infection of other medical conditions
- Cancer screening
- Cancer screening
- Cancer staging and classification
- Cancer survival
- Cancer survivorship
- Cancer target identification
- Cancer therapeutics
- Cancer therapy
- Cancer therapy
- Cancer, palliative and supportive care
- Cardiovascular diseases and cancer
- Clinical and translational research in pancreatic cancer
- Clinical cancer genetics
- Clinical cancer research
- Clinical interests and expertise: Breast cancer diagnosis, prognosis and therapy
- Colorectal cancer
- Colorectal cancer
- Comprehensive cancer centres
- Diagnosis and treatment of esophageal and gastric cancer
- Diet and cancer risk
- Dietary intervention for cancer patients
- Early detection of cancer
- Endogenous hormones and cancer risk
- Endometrial cancer
- Engineered cell therapy for cancers
- Epigenetics (methylation, acetylationb, miRNA) as marker and targets for cancer therapy
- Etiological factors in female cancers
- Factors affecting cancer survival
- Familial gastric cancer
- Fear of cancer recurrence
- Gastroenterology and cancers of the gastrointestinal tract
- Gastrointestinal cancer
- Genetics of pancreatitis and pancreatic cancer
- Genomic and epigenomic alterations in gastrointestinal (GI) cancer;
- Gut microbiome, bacteria/host interaction during cancer development;
- Hereditary Diffuse Gastric cancer
- Hereditary cancer
- Hereditary cancer
- Human cancer
- Infections immunocompromised hosts, including neutropenic cancer patients
- Inflammation and cancer
- Inhibitory receptors on cancer cells as target for therapy
- Investigational therapeutic agents for cancer
- Kinase inhibitors in cancer, neurological and inflammatory disorders
- Lung cancer
- Lung cancer
- Medical oncology with a special interest in lung cancer and breast cancer
- Microbiome and cancer
- Molecular oncology with a special interest in lung cancer and breast cancer
- Neurological complication of systemic cancers
- New combinatorial treatment approaches using immunotherapy for hepato-biliary pancreatic cancers
- Non-alcoholic fatty liver disease and liver cancer in relation to the mechanisms and therapeutic targets;
- Non-invasive colorectal cancer diagnosis
- Novel cancer therapies
- Ovarian cancer
- Pancreatic cancer
- Pancreatic cancer surveillance
- Pancreatic cancer, breast cancer, lung cancer, neuroendocrine tumors
- Pathology of cancer
- Pathophysiology and molecular medicine of autoimmunity and cancer
- Prostate cancer
- Prostate cancer diagnosis
- Pulmonary fibrosis and lung cancer
- Resistance mechanisms to targeted therapies in lung cancer
- Screening and surveillance of pancreatic cancer
- Screening for esophageal cancer
- Secondary cancer in rheumatic diseases
- Skin cancer research and treatment
- Systemic treatment of germ cell cancer
- Systemic treatment of prostate cancer
- Systemic treatment of renal cell cancer
- Systemic treatment of urothelial cancer
- Targeted therapy and drug delivery in cancer
- Testicular cancer
- Understanding the causes of human cancer
- Urological cancers
- mRNA translation in cardiovascular diseases and cancer progression
-
cardiac
- Affinity of cardiac receptors for various drugs
- Cardiac autonomic function
- Cardiac electrophysiology
- Cardiac inflammation
- Cardiac rehabilitation and secondary prevention
- Cardiac repair after a myocardial infarction
- Cellular cardiac electrophysiology
- In vivo cardiac electrophysiology
- Intracellular cardiac electro-mechanical coupling
- Physiology and pathophysiology of cardiac arrhythmias
- Quantitative evaluation of cardiac and CNS receptors with PET
- Sport cardiology, cardiac remodeling of elite athletes
-
cardiology
- Cardiology
- Interventional cardiology
- Molecular biology in cardiology
- Molecular cardiology
- New techniques in interventional cardiology
- Preventive cardiology
- Sport cardiology, cardiac remodeling of elite athletes
- Stem cells in cardiology
-
cardiovascular
- Basic and translational cardiovascular sciences
- Cardiovascular
- Cardiovascular and nutritional epidemiology
- Cardiovascular comorbidity in rheumatic diseases
- Cardiovascular disease
- Cardiovascular disease prevention
- Cardiovascular disease prevention
- Cardiovascular diseases
- Cardiovascular diseases and cancer
- Cardiovascular epidemiology
- Cardiovascular epidemiology
- Cardiovascular genetics
- Cardiovascular medicine
- Cardiovascular pharmacology
- Cardiovascular pharmacotherapy
- Cardiovascular risk factors and diseases
- Cardiovascular risk factors diagnosis and management
- Clinical trials in hypertension and other cardiovascular diseases
- Computer analysis of the cardiovascular signals
- Diet and cardiovascular disease
- Epidemiology and pathogenesis of atherosclerosis and cardiovascular disease
- Hemodynamic effects of cardiovascular drugs
- Hypertension and cardiovascular epidemiology
- Hypertension and cardiovascular prevention
- Lipid metabolism and cardiovascular risk factors
- Pathophysiology of thrombosis and cardiovascular diseases
- Pharmacology of cardiovascular system
- Reflex regulation of cardiovascular system in physiologic and pathologic states
- Stress/sleep and the cardiovascular system
- The role of diabetes in cardiovascular disease
- Type 2 diabetes and cardiovascular and other diabetic late complications
- mRNA translation in cardiovascular diseases and cancer progression
- “Real life” research on adherence/inertia to cardiovascular treatments
-
care
- ALS/MND, clinical, neurophysiological, pathological, epidemiological and financial/ethical/care aspectsClinical neurology
- Acute stroke care
- Advance care in non-malignant disease conditions
- Cancer, palliative and supportive care
- Care pathways and the healthcare organization and quality of care
- Competence of nurses for quality care
- Critical care
- Dementia care
- Evaluation of person-centred care interventions using controlled designs
- Evaluation of the quality of nursing care
- Fungal infections in the intensive care unit
- Health Care Management and chronic disease conditions
- Health care research based on patient cohorts and epidemiologic registers
- Home care
- Individualised care
- Individualised care enviroment
- Intensive care
- Involvement of service users and families in care planning in secondary care mental health services
- Mental health care
- Neuro-intensive care
- New theoretical developments in caring, 'humanisation of care', new theory existential wellbeing and its absence
- Novel development of 'Lifeworld led care'
- Nurse staffing and patient safety and quality of care
- Nursing and care ethics
- Palliative care
- Primary care
- Research in clinical nursing/health care, consisting of analysis and instrumentation
- Research in health care and nursing ethics, consisting of
- Research in nursing/health care education/pedagogics, consisting of
- Self care
- Tele-health care
- Theoretical applications of lifeworld led care to practice
- Translation of genomic findings into clinical care
- Value-based health care
-
cell
- Activation of dendritic cells and macrophages to bridge innate and adaptive immunity in the lung
- Adult spindle cell rhabdomyosarcoma (MYOD1)
- Apoptosis and cell cycle
- Apoptosis and other types of cell death
- B cell development and function
- Basic immunology, focus on CD4 T cells, cytokines and antigen presenting cells
- Cell adhesion, chemokines and angiogenesis
- Cell and molecular mechanism of hepatic and intestinal fibrogenesis
- Cell biology
- Cell death
- Cell hydration and cell function
- Cell mediated immunity
- Cytometry and cell sorting
- Dendritic cell subsets and regulatory T cells in the tumor microenvironment
- Dendritic cells and their subsets
- Endothelial cell dysfunction
- Endothelial cells
- Engineered cell therapy for cancers
- Engineering cell
- Gene and cell therapy
- Germ cell neoplasia in situ (GCNIS)
- Hematopoietic stem cells
- Hemopoietic stem cell transplantation
- Hypoxia effects on mast cells
- IPF Treg cells
- Immunobiology of human dendritic cells
- Induction of tumor cell senescence by the immune system
- Inhibitory receptors on cancer cells as target for therapy
- Innate immune cell reprogramming, metabolic and epigenetic reprogramming
- Innate immune cells in the skin
- Keratinocyte/epithelial cell biology
- Liver cell biology
- Mast cell and eosinophil activating and inhibitory receptors
- Mast cell and eosinophil functions in allergic diseases
- Molecular events and Interactions between immunocompetent cells, inflammatory cells, epithelial cells in allergic inflammation and airways remodelling
- Natural Killer Cell Receptors
- Natural killer (NK) cell biology
- Pathophysiology, cell biology and genetics of pancreatic disorders
- Recognition of microbas by epidermal cells
- Redox metabolism in melanoma and circulating tumor cells
- Role of mast cells in health and diseases
- Signal transduction in the myocardial cell
- Stem cell biology
- Stem cell science
- Stem cell therapy for severe skin fragility syndromes
- Stem cell transplantation
- Stem cells
- Stem cells in cardiology
- Systemic treatment of germ cell cancer
- Systemic treatment of renal cell cancer
- T cells, B cells and plasma cells
- Tumor vaccine: exosomes, dendritic cells
-
chronic
- Acute and chronic heart failure
- Acute and chronic pancreatitis
- Anemia of chronic disease
- Antiviral therapy of chronic hepatitis
- Basic, translational and clinical research in chronic airway diseases (COPD, asthma)
- Chronic Obstructive Pulmonay Disease (COPD): Guidelines – Exacerbations – Physical Activity – Gas Exchange – Pulmonary Vascular Changes
- Chronic disease
- Chronic disease epidemiology
- Chronic exposure to xenobiotics and impact on human health and linking to diseases
- Chronic fatigue syndrome
- Chronic illness
- Chronic illness in childhood and adolescence
- Chronic inflammatory autoimmune diseases
- Chronic kidney disease
- Chronic kidney disease and diabetes
- Chronic obstructive pulmonary disease
- Chronic obstructive pulmonary disease
- Chronic obstructive pulmonary diseases
- Chronic pancreatitis
- Chronic viral hepatitis
- Clinical and translational research in chronic pancreatitis
- Development of biomarkers and technologies for the non-invasive evaluation of disease progression in chronic liver diseases
- Epidemiology and public health aspects of chronic hepatitis B, C and D
- Health Care Management and chronic disease conditions
- Immunity (cytokine research) and chronic liver diseases
- Investigation of chronic multimorbidity
- Rehabilitation and personalised management in COPD and chronic heart failure
- Remote delivery of interventions (telephone, computerised therapies) with Chronic Widespread Pain
- Respiratory Medicine: specifically asthma and chronic obstructive pulmonary disease
- Telomeres length, chronic diseases and aging. Focus on biomarkers and modulation of telomerase
-
clinical
- ALS/MND, clinical, neurophysiological, pathological, epidemiological and financial/ethical/care aspectsClinical neurology
- Atherosclerosis related disease biomarkers discovery, risk prediction and clinical testing
- Basic, translational and clinical research in chronic airway diseases (COPD, asthma)
- COVID-19 vaccine clinical trials
- Cancer clinical trials
- Clinical Hepatology
- Clinical Neurology
- Clinical academic training and careers
- Clinical and experimental hepatology
- Clinical and experimental immunology
- Clinical and experimental nephrology
- Clinical and experimental rheumatology
- Clinical and immunopharmacological activities of Biological Responses Modifiers
- Clinical and molecular immunology
- Clinical and molecular phenotyping of asthma
- Clinical and translational research in acute pancreatitis
- Clinical and translational research in chronic pancreatitis
- Clinical and translational research in pancreatic cancer
- Clinical applications of gut microbiome
- Clinical applications of gut microbiota
- Clinical aspects of dementia
- Clinical bioinformatics
- Clinical cancer genetics
- Clinical cancer research
- Clinical chemistry, biochemistry and laboratory medicine
- Clinical cognitive neuroscience in psychiatry
- Clinical drug research
- Clinical endocrinology
- Clinical epidemiological studies
- Clinical epidemiology
- Clinical genetics
- Clinical immunology
- Clinical immunology
- Clinical implementation of new imaging techniques
- Clinical infectious disease epidemiologist
- Clinical infectious diseases
- Clinical interests and expertise: Breast cancer diagnosis, prognosis and therapy
- Clinical laboratory diagnostics in veterinary medicine
- Clinical management of Type 1 and Type 2 diabetes
- Clinical medicine
- Clinical microbiology
- Clinical neurology
- Clinical neurology of ataxias
- Clinical neurology, with special regard to stroke
- Clinical neurophysiology
- Clinical neuroscience
- Clinical neurosciences
- Clinical oncology/hematology
- Clinical pharmacological studies in the field of neurological disorders
- Clinical pharmacology
- Clinical pharmacology
- Clinical pharmacology and clinical trials
- Clinical pharmacy
- Clinical pioneer of successful substrate reduction therapy in sphingolipid diseases
- Clinical preventive practices
- Clinical research
- Clinical research, translational research
- Clinical studies and trials in major rheumatic diseases
- Clinical toxicology
- Clinical trial design
- Clinical trials
- Clinical trials
- Clinical trials and systematic reviews, particularly of interventions in children
- Clinical trials development
- Clinical trials for pancreatic diseases
- Clinical trials in hypertension and other cardiovascular diseases
- Early clinical development
- Early clinical trials in solid tumours
- Early phase clinical trials
- Experimental and clinical investigations of the mechanisms of arrhythmias
- Forensic and clinical issues of anabolic and drugs of abuse
- Healthcare-associated infections, with emphasis on their clinical epidemiology
- Heterogeneity in its clinical manifestations
- Informing health policy through minimum datasets and clinical information
- Novel drugs and Clinical Trials
- Observational clinical trials in acute pancreatitis (APPLE, PINEAPPLE, EASY, LIFESPAN)
- Oncology: experimental and clinical
- Organisation of Clinical Research
- Pediatric clinical pharmacology
- Preclinical and clinical research in obstructive airway diseases (Asthma and Chronic Obstructive Pulmonary Disease)
- Randomised clinical trials
- Randomized interventional clinical trials in acute pancreatitis (GOULASH, PREPAST, EMILY)
- Regulatory and ethical aspects of clinical research
- Research in clinical nursing/health care, consisting of analysis and instrumentation
- Running of several clinical and autopsy cohort studies (TVS, TSDS, YFS-3G, FINCAVAS)
- Statistics and clinical trials
- Translation of genomic findings into clinical care
- Use of next generation sequencing to measure residual disease (leukemic cells) in clinical trials
- Veterinary biochemistry and particularly veterinary clinical biochemistry
- Veterinary clinical pathology
-
control
- Appetite control and disordered eating
- Computational tools to optimize glycaemic control
- Evaluation of person-centred care interventions using controlled designs
- Highlow randomized controlled trials
- Infection Control
- Inflammatory mechanisms: transcriptional control of inflammatory genes, transcription factors, chromatin remodell
- Informing control of COVID19 through data linkage
- Injury prevention and control
- Randomized control trials
- Reflex and central control of the circulation in health and disease
- Sensorimotor control
-
data
- (Nutritional) biomarker research, including omics data
- Analysis of high-dimensional data
- Big data in medicine
- Big data, environment and health/wellbeing
- Data analysis
- Individual-patient data meta-analyses
- Informing control of COVID19 through data linkage
- Machine learning approaches to big data
- Mass cytometry and analysis of high dimensional data
- Population data science
- Privacy protecting data linkage
- Secondary use of administrative and other real-world data in medical research
- Time-varying effects in survival data
- Translation of biomarker and neuropharmacological data from basics to clinic
-
development
- Antifungal pharmacology and drug development
- Antimicrobial drug development
- B cell development and function
- Beta-cell development
- Cancer drug development
- Cancer immunotherapy and cancer vaccine development
- Capacity and capability development
- Clinical trials development
- Development
- Development and implementation of MRI Fe-(USPIO) contrast agents
- Development and validation of (dynamic) contrast-enhanced magnetic resonance imaging (MRI) of bone and soft tissue tumours
- Development of analytical methods for testing of drugs and xenobiotics.
- Development of antimetabolites, including antifolates
- Development of biochemical assays for use in veterinary laboratories
- Development of biomarkers and technologies for the non-invasive evaluation of disease progression in chronic liver diseases
- Development of macromolecular and nano systems for targeting and reducing toxicity of drugs
- Development of new more effective anti-seizure medications
- Development of positron emission tomography for medicine and medical research
- Development of prophylactic and therapeutic approaches
- Development of reproductive systems
- Drug development
- Drug development and drug discovery in general
- Drug discovery and development
- Early clinical development
- Fetal development
- Genetics of disorders of hair development
- Gut microbiome, bacteria/host interaction during cancer development;
- Human development
- Immunoassay development and validation
- Leadership and Professional development
- Lipid nanoparticle and polymer development
- Macrophage in development
- Medical device development for skin diseases
- Medical statistics of child growth and development
- Neutrophil development and function
- New theoretical developments in caring, 'humanisation of care', new theory existential wellbeing and its absence
- Novel development of 'Lifeworld led care'
- Preclinical development of immune checkpoint blockers
- Prognostic model development and validation
- Qualitative enquiry development in nursing particularly phenomenology
- Questionnaire development and validation
- Role of the hepatic stroma in the development of hepatocellular carcinoma and cholangiocarcinoma
- System biology - omics, statistical tool coding and development
- Therapy development/experimental medicine
- Transcriptional signaling involved in the development and progression of tumors
- Vaccine development
-
diabetes
- Chronic kidney disease and diabetes
- Clinical management of Type 1 and Type 2 diabetes
- Complications of Type 1 and Type 2 diabetes
- Diabetes
- Diabetes
- Diabetes diagnosis
- Diabetes treatment
- Diet and diabetes risk
- Genetics of complex diseases such as atherosclerosis, kidney diseases, diabetes mellitus
- Genetics of type 2 diabetes, and gene diet interactions in regulation of lipid and glucose metabolism
- Maternal gestational diabetes and lifelong health of the offspring
- Mechanisms of insulin resistance, mitochondrial function and inflammation in obesity, diabetes mellitus and fatty liver diseases
- Monogenic diabetes
- Neonatal diabetes
- Obesity, diabetes, dyslipidemia and other metabolic abnormalities
- Precision medicine in diabetes
- Prevention and treatment of hypertension, hyperlipidemia, congestive heart failure and diabetes
- Prevention of type 2 diabetes by changing lifestyles
- Role of microbiota in obesity and type 2 diabetes
- The role of diabetes in cardiovascular disease
- Type 2 diabetes and cardiovascular and other diabetic late complications
- Type 2 genomic/genetic diabetes and obesity (including microRNA and long non-coding RNA)
-
disease
- Advance care in non-malignant disease conditions
- Alcoholic liver disease
- Alzheimer´s disease
- Alzheimer’s disease
- Anemia of chronic disease
- Atherosclerosis related disease biomarkers discovery, risk prediction and clinical testing
- Autoimmune diseases
- Autoimmune diseases and treatment (immunosuppression)
- Autoimmune diseases of the skin & psoriasis
- Autoimmune, inflammatory, infectious, and vascular disease conditions
- Basic, translational and clinical research in chronic airway diseases (COPD, asthma)
- Biomarkers of disease of animals
- Cancer risk in patients with pancreatitis, cystic fibrosis, end-stage renal disease, hepatitic C virus infection of other medical conditions
- Cardio-metabolic diseases
- Cardio-metabolomic diseases
- Cardiometabolic and renal disease
- Cardiovascular comorbidity in rheumatic diseases
- Cardiovascular disease
- Cardiovascular disease prevention
- Cardiovascular disease prevention
- Cardiovascular diseases
- Cardiovascular diseases and cancer
- Cardiovascular risk factors and diseases
- Cerebral hemodynamics in stroke-risk diseases and stroke
- Cerebrovascular disease
- Cerebrovascular diseases
- Cerebrovascular diseases and stroke
- Chronic Obstructive Pulmonay Disease (COPD): Guidelines – Exacerbations – Physical Activity – Gas Exchange – Pulmonary Vascular Changes
- Chronic disease
- Chronic disease epidemiology
- Chronic exposure to xenobiotics and impact on human health and linking to diseases
- Chronic inflammatory autoimmune diseases
- Chronic kidney disease
- Chronic kidney disease and diabetes
- Chronic obstructive pulmonary disease
- Chronic obstructive pulmonary disease
- Chronic obstructive pulmonary diseases
- Clinical infectious disease epidemiologist
- Clinical infectious diseases
- Clinical pioneer of successful substrate reduction therapy in sphingolipid diseases
- Clinical studies and trials in major rheumatic diseases
- Clinical trials for pancreatic diseases
- Clinical trials in hypertension and other cardiovascular diseases
- Cognitive impairment in systemic disease and multimorbidity
- Coronary artery disease
- Coronary artery disease
- Crohn's disease
- Development of biomarkers and technologies for the non-invasive evaluation of disease progression in chronic liver diseases
- Developmental origins of health and disease
- Developmental plasticity in relation to later health and disease
- Diagnostic tools for mitochondrial diseases
- Diet and cardiovascular disease
- Disease ecology
- Disease prevention
- Diseases associated to molecular defects of receptor function
- Emerging respiratory infectious diseases
- Environmental epidemiology and environmental determinants of diseases
- Environmental triggers of GI diseases
- Epidemiological analysis of pancreatic diseases (AP, CP, PC, AIP)
- Epidemiology and aetiology of Inflammatory Bowel Disease (IBD)
- Epidemiology and pathogenesis of atherosclerosis and cardiovascular disease
- Epidemiology of GI diseases
- Epidemiology of age-related neurological diseases
- Extra- and intracranial ultrasound in vascular diseases
- Familial Alzheimer's disease
- Functional and structural architecture of the human brain in health and disease
- Gastro-oesophageal reflux disease (GORD)
- Genetic basis of human disease
- Genetic basis of human diseases
- Genetic diseases of the pancreas
- Genetic epidemiology of respiratory diseases
- Genetics (GWAS, NGS, single-cell-RNAseq, transcriptomics) of complex traits and diseases
- Genetics of complex diseases such as atherosclerosis, kidney diseases, diabetes mellitus
- Genetics of psychiatric diseases
- Genetics of rheumatic diseases
- Health Care Management and chronic disease conditions
- Heart disease in women
- Heart failure disease management
- Hepatology, liver disease
- Hirschsprung's disease and allied disorders
- Human muscle spindle anatomy and pathology in neuromuscular disease
- Hypoxia and renal disease
- Immune modulation and the link between communicable and non-communicable diseases
- Immunity (cytokine research) and chronic liver diseases
- Infectious Diseases
- Infectious and tropical diseases
- Infectious disease epidemiology
- Infectious disease epidemiology, notably Covid-19
- Infectious diseases
- Infectious diseases (COVID-19)
- Inflammatory bowel disease
- Inflammatory bowel disease (IBD)
- Inflammatory bowel diseases and pathogenesis
- Inflammatory kidney disease
- Inflammatory skin disease
- Inherited skin disease
- Inherited skin disease
- Innate immune system, inflammation and metabolic diseases
- Insect-borne diseases
- Interstitial lung diseases
- Invasive fungal diseases
- Iron as a modulator of inflammation to metabolic diseases
- Kawasaki disease, a paediatric vasculitis of the heart
- Liver disease
- Liver disease
- Mast cell and eosinophil functions in allergic diseases
- Mechanisms of disease
- Mechanisms of insulin resistance, mitochondrial function and inflammation in obesity, diabetes mellitus and fatty liver diseases
- Mediators of inflammation, oxidative stress in lung disease
- Medical device development for skin diseases
- Mental diseases (posttraumatic stress syndrome)
- Mitochondrial diseases
- Molecular genetics and pathogenesis of neurodegenerative diseases
- Muscle physiology and diseases
- Musculoskeletal disease
- Neurological diseases
- Neuromuscular disease
- Neuropharmacology of Parkinson´s disease
- New antiallergic drugs and new strategies in the allergic disease treatment
- Non-alcoholic fatty liver disease and liver cancer in relation to the mechanisms and therapeutic targets;
- Non-communicable disease epidemiology
- Non-communicable diseases
- Non-communicable diseases
- Nonalcoholic fatty liver disease
- Noncommunicable diseases
- Parasitology & neglected and poverty related tropical diseases (helminths and malaria)
- Parkinson disease
- Parkinson's disease
- Parkinson's disease
- Parkinson’s disease
- Parkinson’s disease (brain repair)
- Pathogen-host-interactions during infectious diseases in immune-competent and immune-compromised hosts
- Pathogenesis of eosinophilic diseases
- Pathogenesis of infectious diseases
- Pathogenesis of inflammatory skin diseases
- Pathophysiology of thrombosis and cardiovascular diseases
- Patients Reported Outcomes & Quality of life evaluation in patients with respiratory and allergic diseases
- Pig infectious diseases
- Poverty-related diseases
- Preclinical and clinical research in obstructive airway diseases (Asthma and Chronic Obstructive Pulmonary Disease)
- Progression of renal disease
- Protein misfolding diseases
- Pulmonary heart disease
- Pulmonary vascular disease
- Reflex and central control of the circulation in health and disease
- Respiratory Diseases
- Respiratory Medicine: specifically asthma and chronic obstructive pulmonary disease
- Respiratory disease
- Rheumatic diseases
- Role of mast cells in health and diseases
- Secondary bone loss in rheumatic diseases
- Secondary cancer in rheumatic diseases
- Systemic lupus erythematosus (SLE) is a systemic autoimmune disease
- Telomeres length, chronic diseases and aging. Focus on biomarkers and modulation of telomerase
- The role of diabetes in cardiovascular disease
- Therapeutics of Immune Mediated Inflammatory Diseases (IMID)
- Transgenic models of human disease
- Transgenic models of human disease
- Treatment of mitochondrial diseases
- Use of next generation sequencing to measure residual disease (leukemic cells) in clinical trials
- Vascular disease
- Vectors and vector-borne diseases
- Wildlife parasites and parasitic diseases
- mRNA translation in cardiovascular diseases and cancer progression
-
disorder
- Adrenal disorders and tumors
- Affective disorders
- Allergic disorders
- Appetite control and disordered eating
- Autism spectrum disorder
- Autoinflammatory disorders
- Bipolar disorders
- Clinical pharmacological studies in the field of neurological disorders
- Deep brain stimulation in mental disorders
- Dementia and neurodegenerative disorders
- Disorders of gonadal function
- Experimental models of neurological disorders (migraine, Parkinson's disease, Huntington's disease, mulitple sclerosis)
- Functional disorders and body stress disorder
- Genetic and environmental imbalances of iron homeostasis in systemic disorders
- Genetics of disorders of hair development
- Genetics of the Mood Disorder
- Headache disorders
- Hirschsprung's disease and allied disorders
- Immune treatment of hematological disorders
- Investigation of newly synthesized kynurenic acid analogues in different animal models of neurological disorders
- Keratinizing disorders
- Keratinizing disorders
- Keratinizing skin disorders
- Kinase inhibitors in cancer, neurological and inflammatory disorders
- Liver disorders
- Mood disorder
- Movement disorders
- Neurochemical investigations in models of neurological disorders (excitotoxins, peptides, kynurenines)
- Neurodegenerative disorders
- Neurodevelopmental disorders
- Neurological disorders
- Neurological disorders
- Neuropsychiatric disorders
- Non-pharma interventions in neurodevelopmental disorders
- Obesity-related disorders
- Pathophysiology, cell biology and genetics of pancreatic disorders
- Pelvic floor disorders
- Pharmacological interventions in neurodevelopmental disorders
- Pituitary disorders
- Posttraumatic stress disorder
- Pre- and postnatal developmental influences on child obesity, allergic disorders and neurobehavioural outcomes
- Psychiatric disorders
- Role of gut microbiota in gastrointestinal disorders
- Thrombotic and bleeding disorders
- Transcranial magnetic stimulation in mental disorders
- Whole-body cryotherapy in mental disorders
-
drug
- Acute recreational drug toxicity
- Adverse drug reactions
- Affinity of cardiac receptors for various drugs
- Antifungal pharmacology and drug development
- Antimicrobial drug development
- Aptamer-based translational medicine and drug discovery
- Cancer drug development
- Cancer drug resistance
- Clinical drug research
- Development of analytical methods for testing of drugs and xenobiotics.
- Development of macromolecular and nano systems for targeting and reducing toxicity of drugs
- Drug delivery
- Drug delivery systems
- Drug development
- Drug development and drug discovery in general
- Drug discovery and development
- Drug repurposing
- Drug resistance mechanisms
- Drug safety
- Drug transport
- Drug transporters and drug metabolism
- Drugs and memory
- Epigenetics and drug metabolizing enzymes and transporters
- Forensic and clinical issues of anabolic and drugs of abuse
- Gene and drug delivery
- Hemodynamic effects of cardiovascular drugs
- Mechanisms of drug resistance in epilepsy
- Molecular toxicity mechanisms of drugs and pesticides, pharmacokinetics, metabolism, P450 isoforms, gene expression profiling
- New antiallergic drugs and new strategies in the allergic disease treatment
- New drugs
- Novel drugs and Clinical Trials
- Oral drug delivery platform technologies
- Pharmacogenetics of anticancer drugs (both conventional chemotherapy and "targeted" drugs
- Pharmacological and toxicological in vivo and in vitro studies with drugs, pesticides, and chemicals and their interpretation.
- Resistance to anti-signalling drugs
- Safety and efficacy of drugs in children
- Side-effects of medicinal drugs
- Signal pathways of oxidative stress, apoptosis, inflammation, and DNA methylation and drug therapeutic effect.
- Targeted therapy and drug delivery in cancer
- The physiology and pathophysiology of drug efflux transporters
- Toxicology of synthetic and biogenic drugs
-
education
- Clinician Scientist education
- Doctoral education
- Doctoral education capacity building with impacts nationally and internationally
- Education
- Empowering patient education
- Evaluation of outcomes of nursing education
- Introduced glycobiology education
- Medical education
- Medical education
- Mentoring Doctoral Education
- Postdoctoral Education Stroke rehabilitation Post stroke depression’
- Research in nursing/health care education/pedagogics, consisting of
-
effect
- Cognitive effects of benzodiazepines
- Effects of Cannabis and cannabinoids on humans
- Health effects of air pollution
- Health effects of dietary fatty acids
- Health effects of dietary fibre
- Hemodynamic effects of cardiovascular drugs
- Hypoxia effects on mast cells
- Non-specific effects of vaccines: Immune training effects
- Sex-differential effects of interventions
- Signal pathways of oxidative stress, apoptosis, inflammation, and DNA methylation and drug therapeutic effect.
- Time-varying effects in survival data
-
endocrinology
- Andrological and paediatric endocrinology
- Clinical endocrinology
- Endocrinology
- Endocrinology
- History of endocrinology
- Paediatric endocrinology
- Reproductive endocrinology
- Thyroid endocrinology
-
environmental
- Environmental and health inequalities
- Environmental and occupational health and epidemiology
- Environmental epidemiology
- Environmental epidemiology
- Environmental epidemiology and environmental determinants of diseases
- Environmental health
- Environmental risk assessment
- Environmental sustainability
- Environmental triggers of GI diseases
- Exposure to industrial or environmental pollutants in air, food and water
- Genetic and environmental imbalances of iron homeostasis in systemic disorders
- Impact and mechanisms of environmental pollution on the respiratory system
- Occupational and environmental epidemiology
-
epidemiology
- Antibiotic resistance, including epidemiology, phenotypic and genotypic detection
- Asthma epidemiology
- Cancer epidemiology
- Cancer epidemiology
- Cancer epidemiology and cancer prevention
- Cardiovascular and nutritional epidemiology
- Cardiovascular epidemiology
- Cardiovascular epidemiology
- Chronic disease epidemiology
- Clinical epidemiology
- Descriptive epidemiology
- Developmental epidemiology
- Environmental and occupational health and epidemiology
- Environmental epidemiology
- Environmental epidemiology
- Environmental epidemiology and environmental determinants of diseases
- Epidemiology
- Epidemiology
- Epidemiology and aetiology of Inflammatory Bowel Disease (IBD)
- Epidemiology and pathogenesis of atherosclerosis and cardiovascular disease
- Epidemiology and public health aspects of chronic hepatitis B, C and D
- Epidemiology of GI diseases
- Epidemiology of age-related neurological diseases
- Epidemiology of zoonoses
- Epigenetic epidemiology
- Epilepsy, epidemiology, outcomes
- Genetic epidemiology
- Genetic epidemiology
- Genetic epidemiology of respiratory diseases
- HIV/AIDS and Sexually Transmitted Infection epidemiology
- Healthcare-associated infections, with emphasis on their clinical epidemiology
- Hypertension and cardiovascular epidemiology
- Infectious disease epidemiology
- Infectious disease epidemiology, notably Covid-19
- Influenza and SARS CoV 2 epidemiology
- Molecular tools for bacterial epidemiology
- Neurological conditions, epidemiology, outcomes
- Non-communicable disease epidemiology
- Nutritional epidemiology
- Nutritional epidemiology
- Occupational and environmental epidemiology
- Occupational epidemiology
- Paediatric and perinatal epidemiology
- Spatial epidemiology
- Tobacco epidemiology
-
experimental
- Clinical and experimental hepatology
- Clinical and experimental immunology
- Clinical and experimental nephrology
- Clinical and experimental rheumatology
- Experimental Rheumatology
- Experimental acute kidney injury
- Experimental and clinical investigations of the mechanisms of arrhythmias
- Experimental animal models of infections (endocarditis, osteomyelitis)
- Experimental behavioral pharmacology
- Experimental design and statistics
- Experimental focal ischemia models
- Experimental medicine
- Experimental medicine
- Experimental models of neurological disorders (migraine, Parkinson's disease, Huntington's disease, mulitple sclerosis)
- Experimental neurophysiology
- Experimental psychopathology
- Immunology: experimental (translational and basic research)
- Oncology: experimental and clinical
- Therapy development/experimental medicine
-
factor
- Biochemistry of blood coagulation factors
- Bronchial Challenge Tests: AMP – Histamine – Mannitol – Methacholine – Platelet Acticating Factor
- Cardiovascular risk factors and diseases
- Cardiovascular risk factors diagnosis and management
- Dietary factors and weight changes in regulation of gene expression in adipose tissue and blood
- Endogen vasoactive arrhythmogenic factors
- Etiological factors in female cancers
- Factors affecting cancer survival
- Growth factor receptors and antibodies
- Growth factors
- Identification of new risk factors: linked to diet, obesity and physical activity, occupational and lifestyle hazards
- Inflammatory mechanisms: transcriptional control of inflammatory genes, transcription factors, chromatin remodell
- Lipid metabolism and cardiovascular risk factors
- Modifiable risk factors
-
failure
- Acute and chronic heart failure
- Central sleep apnea in systolic heart failure
- Heart failure
- Heart failure
- Heart failure and atrial fibrillation
- Heart failure and comorbidities
- Heart failure definition and classification
- Heart failure disease management
- Heart failure pathophysiology
- Heart failure prevention
- Heart failure prognosis
- Invasive and noninvasive imaging in heart failure
- Non-pharmacological treatment of heart failure
- Pathophysiology and treatment options of heart failure
- Prevention and treatment of hypertension, hyperlipidemia, congestive heart failure and diabetes
- Rehabilitation and personalised management in COPD and chronic heart failure
- Respiratory failure
- Ventilatory failure
-
function
- Analysis of the structures and functions of proteinases
- Asbestos Exposure: Lung Function – Pathology – Small Airways Dysfunction
- B cell development and function
- Brain function and brain health
- Brain tumor and brain function protection
- Brainstem function protection
- Cardiac autonomic function
- Cell hydration and cell function
- Diseases associated to molecular defects of receptor function
- Disorders of gonadal function
- Elucidated the tumour suppressor function of EXT1/2 in osteochondroma and peripheral chondrosarcoma
- Gut barrier function
- Ion channel function and dysfunction
- Lung function
- Lung function trajectories through the lifespan (trajectome)
- Mast cell and eosinophil functions in allergic diseases
- Mechanisms of insulin resistance, mitochondrial function and inflammation in obesity, diabetes mellitus and fatty liver diseases
- Myocardial autocrine function
- Neutrophil development and function
- Ovarian function
- Traditional immunological functions of APCs
- Upper limb function
-
gene
- Artificial gene circuits and gene regulatory networks
- Cloned causative mutations in the IDH1 and IDH2 genes in enchondroma, central chondrosarcoma and dedifferentiated chondrosarcoma
- Cloning and gene analysis of proteases, cytokines and chemokines
- Diagnostic, prognostic and predictive significance of gene expression
- Dietary factors and weight changes in regulation of gene expression in adipose tissue and blood
- Enzyme targeting, gene transfer
- Gene and cell therapy
- Gene and drug delivery
- Gene expression signatures
- Gene transfer vectors
- Genetic polymorphisms as markers for resistance, to select driver genes and provide personalized therapy of patients
- Genetics of type 2 diabetes, and gene diet interactions in regulation of lipid and glucose metabolism
- Identification and characterization of gene alterations
- Inflammatory mechanisms: transcriptional control of inflammatory genes, transcription factors, chromatin remodell
- Influences of genes based on twins and on genotyping
- Molecular toxicity mechanisms of drugs and pesticides, pharmacokinetics, metabolism, P450 isoforms, gene expression profiling
-
genetics
- Behavior genetics
- Cancer genetics
- Cardiovascular genetics
- Clinical cancer genetics
- Clinical genetics
- Genetics
- Genetics
- Genetics & heredity
- Genetics (GWAS, NGS, single-cell-RNAseq, transcriptomics) of complex traits and diseases
- Genetics and genomics of thoracic malignancies
- Genetics of complex diseases such as atherosclerosis, kidney diseases, diabetes mellitus
- Genetics of disorders of hair development
- Genetics of isolated human malformations
- Genetics of pancreatitis and pancreatic cancer
- Genetics of primary ovarian insufficiency
- Genetics of psoriasis
- Genetics of psychiatric diseases
- Genetics of rheumatic diseases
- Genetics of the Mood Disorder
- Genetics of type 2 diabetes, and gene diet interactions in regulation of lipid and glucose metabolism
- Human biochemical genetics
- Human genetics
- Human molecular genetics
- Lymphoma genetics
- Molecular genetics
- Molecular genetics
- Molecular genetics and pathogenesis of neurodegenerative diseases
- Molecular pathogenesis and genetics of bone and soft tissue sarcomas
- Pathophysiology, cell biology and genetics of pancreatic disorders
- Population genetics
- Psychiatric Genetics
- Quantitative genetics
- Statistical genetics
-
health
- Academic health systems
- Adults born preterm as a model to understand molecular and physiological mechanisms linking early life events with lifelong health
- Air pollution and human health
- Allied health professions
- Animal health
- Applied health research
- Applied health research
- Arts & Health
- Arts & health
- Big data, environment and health/wellbeing
- Brain function and brain health
- Chronic exposure to xenobiotics and impact on human health and linking to diseases
- Climate change and Health
- Developmental origins of health and disease
- Developmental plasticity in relation to later health and disease
- Environmental and health inequalities
- Environmental and occupational health and epidemiology
- Environmental health
- Epidemiology and public health aspects of chronic hepatitis B, C and D
- Ethnic minority health
- Foot health
- Functional and structural architecture of the human brain in health and disease
- Global climate change and human health
- Global health
- Global health
- Global health economics and priority setting
- Global health metrics
- Global public health
- Health Care Management and chronic disease conditions
- Health behavior change
- Health care research based on patient cohorts and epidemiologic registers
- Health crisis management
- Health economics
- Health effects of air pollution
- Health effects of dietary fatty acids
- Health effects of dietary fibre
- Health financing
- Health impact assessment
- Health of vegetarians and vegans
- Health policies
- Health policy
- Health policy evaluation
- Health promotion
- Health services
- Health services research
- Health survey methodology
- Health systems and policy
- Health workforce planning, recruitment, skill-mix and retention
- Implementation science in health
- Informing health policy through minimum datasets and clinical information
- Involvement of service users and families in care planning in secondary care mental health services
- Lifelong health after preterm birth
- Low intensity psychological interventions for common mental health conditions (Depression and anxiety) in Primary Mental Health Services
- Lower limb health
- Maternal and child health in low-resource settings
- Maternal and perinatal health
- Maternal gestational diabetes and lifelong health of the offspring
- Mental health
- Mental health
- Mental health care
- Mental health trial design and analysis
- Metabolic basis of health and diseased angiogenesis
- Migrant health
- National health and biomedical sciences research strategy
- Neuroproteomics and genomics in health and in neurodegeneration
- ONE health
- Oceans and human health/wellbeing
- One Health
- One health antimicrobial resistance
- Plant-based diets and long-term health
- Population health
- Population medicine and public health
- Preconception health
- Prisoner health
- Public Health Specialist
- Public health
- Public health
- Public health measures to reduce COVID-19 transmission, especially in young people
- Public health, particularly new public health
- Reflex and central control of the circulation in health and disease
- Reproductive health
- Research in clinical nursing/health care, consisting of analysis and instrumentation
- Research in health care and nursing ethics, consisting of
- Research in nursing/health care education/pedagogics, consisting of
- Role of deleterious environments on health
- Role of mast cells in health and diseases
- Sexual and reproductive health and rights
- Social history of medicine and public health
- Students’ mental health
- Value-based health care
- Workforce planning and skill mix in health
-
heart
- Acute and chronic heart failure
- Central sleep apnea in systolic heart failure
- Heart disease in women
- Heart failure
- Heart failure
- Heart failure and atrial fibrillation
- Heart failure and comorbidities
- Heart failure definition and classification
- Heart failure disease management
- Heart failure pathophysiology
- Heart failure prevention
- Heart failure prognosis
- Invasive and noninvasive imaging in heart failure
- Kawasaki disease, a paediatric vasculitis of the heart
- Non-pharmacological treatment of heart failure
- Pathophysiology and treatment options of heart failure
- Prevention and treatment of hypertension, hyperlipidemia, congestive heart failure and diabetes
- Pulmonary heart disease
- Rehabilitation and personalised management in COPD and chronic heart failure
-
human
- Air pollution and human health
- Chronic exposure to xenobiotics and impact on human health and linking to diseases
- Effects of Cannabis and cannabinoids on humans
- Functional and structural architecture of the human brain in health and disease
- Genetic basis of human disease
- Genetic basis of human diseases
- Genetics of isolated human malformations
- Global climate change and human health
- Human
- Human Immunology
- Human Leucocyte Antigens (HLA)
- Human biochemical genetics
- Human biomonitoring, monitoring and biomonitoring of xenobiotics in the ecosystem
- Human brain
- Human brain changes throughout the lifespan using magnetic resonance imaging and fetal ultrasound
- Human cancer
- Human development
- Human functional neuroimaging
- Human genetics
- Human identification systems
- Human infection models
- Human molecular genetics
- Human movement analysis
- Human muscle spindle anatomy and pathology in neuromuscular disease
- Human non-genetic inheritance
- Human resource management
- Immunobiology of human dendritic cells
- Mechanisms of functional recovery after stroke in humans
- Non-invasive human imaging techniques with positron-emitting isotopes and magnetic resonance
- Oceans and human health/wellbeing
- Paradigm-shifting studies on the role of ectopic fat stores and nutrient-induced insulin resistance in humans
- Plasticity of the human brain
- Positron emission tomography of the human brain (PET)
- Rare lymphoma in human and veterinary medicine
- Risk assessments evaluation to animals, humans and environment
- Role of the amygdala in human empathy explored with fMRI
- Transgenic models of human disease
- Transgenic models of human disease
- Understanding the causes of human cancer
-
hypertension
- Arterial hypertension
- Clinical trials in hypertension and other cardiovascular diseases
- Consequences of hypertension on the brain
- Endocrine hypertension
- Hypertension
- Hypertension and blood pressure
- Hypertension and cardiovascular epidemiology
- Hypertension and cardiovascular prevention
- Immunopathology of pulmonary arterial hypertension
- Invasive treatments in hypertension
- Obesity-related hypertension
- Portal hypertension
- Prevention and treatment of hypertension, hyperlipidemia, congestive heart failure and diabetes
- Pulmonary Hypertension
- Pulmonary hypertension
- Secondary hypertension
-
imaging
- Abdominal imaging
- Advanced endoscopic imaging and treatment
- Atherosclerosis imaging
- Brain Imaging
- Breast imaging
- Chest imaging
- Computational imaging research
- Development and validation of (dynamic) contrast-enhanced magnetic resonance imaging (MRI) of bone and soft tissue tumours
- Endocrine imaging
- Functional magnetic resonance imaging (fMRI)
- Human brain changes throughout the lifespan using magnetic resonance imaging and fetal ultrasound
- Imaging of energy metabolism in focal ischemia
- Intraoperative imaging of the brain
- Invasive and noninvasive imaging in heart failure
- Magnetic resonance imaging
- Medical imaging
- Molecular imaging
- Molecular imaging
- Multimodal imaging
- New (molecular) non-invasive imaging techniques (nanoMRI, PSMA-PET/CT)
- Urogenital imaging
- Vascular imaging
-
immune
- Breach of immune tolerance
- Cancer antigen discovery and cellular/humoral immune recognition
- Immune mechanism of pancreatitis
- Immune modulation and the link between communicable and non-communicable diseases
- Immune receptors
- Immune senescence and disregulation in relation to lung inflammation
- Immune treatment of hematological disorders
- Immune-metabolism of host pathogen interaction and anti-cancer immune regulation
- Induction of tumor cell senescence by the immune system
- Innate immune cell reprogramming, metabolic and epigenetic reprogramming
- Innate immune cells in the skin
- Innate immune memory, trained innate immunity
- Innate immune response to viral infections
- Innate immune responses
- Innate immune system, inflammation and metabolic diseases
- Non-specific effects of vaccines: Immune training effects
- Preclinical development of immune checkpoint blockers
- Therapeutics of Immune Mediated Inflammatory Diseases (IMID)
- Tumor immune surveillance
- Tumor immune therapy
- Tumor immunological microenvironment and tumor immune evasion mechanisms
-
immunology
- Basic immunology, focus on CD4 T cells, cytokines and antigen presenting cells
- Cancer immunology
- Clinical and experimental immunology
- Clinical and molecular immunology
- Clinical immunology
- Clinical immunology
- Diagnostic and laboratory immunology
- Feline immunology and vaccinology
- Human Immunology
- Immunology
- Immunology
- Immunology of bacterial infections, in particular sepsis and pneumonia
- Immunology of the airways.
- Immunology: experimental (translational and basic research)
- Liver Immunology
- Mucosal immunology
- Special interest in tumor immunology
- Tumor immunology
- Viral immunology
-
immunotherapy
- Biomarkers and adjunctive immunotherapy of infection
- Cancer immunotherapy
- Cancer immunotherapy and cancer vaccine development
- Immunotherapy
- Immunotherapy
- Immunotherapy of sepsis and pneumonia
- New combinatorial treatment approaches using immunotherapy for hepato-biliary pancreatic cancers
- Tumor immunotherapy
-
infection
- Antimicrobial stewardship and treatment of complicated bacterial and fungal infections
- Biomarkers and adjunctive immunotherapy of infection
- Cancer risk in patients with pancreatitis, cystic fibrosis, end-stage renal disease, hepatitic C virus infection of other medical conditions
- Cystic fibrosis, particularly respiratory infections
- Ehrlichial and anaplasmal infections in animals and man
- Endocarditis and foreign body-associated infections
- Experimental animal models of infections (endocarditis, osteomyelitis)
- Feline viral infections, emphasis on retroviruses and coronaviruses
- Fungal infections in the intensive care unit
- HIV/AIDS and Sexually Transmitted Infection epidemiology
- Healthcare-associated infections, with emphasis on their clinical epidemiology
- Human infection models
- ICU Infections
- Immunology of bacterial infections, in particular sepsis and pneumonia
- Infection
- Infection Control
- Infection immunity
- Infections immunocompromised hosts, including neutropenic cancer patients
- Infections in critically ill patients
- Infections in immunocompromised patients
- Innate immune response to viral infections
- Innate immunity and host defence to infection
- Lung infection
- Molecular pathogenesis of mycobacterial infections
- New therapeutic approaches for bacterial infections
- Nosocomial Infections
- Pathogenesis and immunogenetics of invasive fungal infections
- Persistent bacterial infections
- Regulatory pathways of lipid homeostasis and its alterations during infection and inflammation
- Respiratory tract infections
- Respiratory virus infections
- Therapeutic approach of infections caused by Multi-drug/Extremely-drug/Pan-drug resistant gram negative bacteria
- Zoonotic infections with epidemic potential
-
infectious
- Autoimmune, inflammatory, infectious, and vascular disease conditions
- Clinical infectious disease epidemiologist
- Clinical infectious diseases
- Emerging respiratory infectious diseases
- Infectious Diseases
- Infectious and tropical diseases
- Infectious disease epidemiology
- Infectious disease epidemiology, notably Covid-19
- Infectious diseases
- Infectious diseases (COVID-19)
- Pathogen-host-interactions during infectious diseases in immune-competent and immune-compromised hosts
- Pathogenesis of infectious diseases
- Pig infectious diseases
-
inflammation
- Biomarkers of inflammation
- Cardiac inflammation
- Immune senescence and disregulation in relation to lung inflammation
- Inflammation
- Inflammation
- Inflammation and cancer
- Inflammation in COPD
- Innate immune system, inflammation and metabolic diseases
- Iron as a modulator of inflammation to metabolic diseases
- Lung inflammation
- Lung inflammation and oncology
- Mechanism of inflammation in psoriasis
- Mechanisms of insulin resistance, mitochondrial function and inflammation in obesity, diabetes mellitus and fatty liver diseases
- Mediators of inflammation, oxidative stress in lung disease
- Metabolism and inflammation
- Molecular events and Interactions between immunocompetent cells, inflammatory cells, epithelial cells in allergic inflammation and airways remodelling
- Molecular mechanisms of inflammation
- Regulatory pathways of lipid homeostasis and its alterations during infection and inflammation
- Signal pathways of oxidative stress, apoptosis, inflammation, and DNA methylation and drug therapeutic effect.
- Synovial inflammation
- Tumour inflammation
-
innate
- Activation of dendritic cells and macrophages to bridge innate and adaptive immunity in the lung
- Innate and adaptive immunity in the airways
- Innate anti-cancer Immunity
- Innate immune cell reprogramming, metabolic and epigenetic reprogramming
- Innate immune cells in the skin
- Innate immune memory, trained innate immunity
- Innate immune response to viral infections
- Innate immune responses
- Innate immune system, inflammation and metabolic diseases
- Innate immunity
- Innate immunity
- Innate immunity and host defence to infection
-
interaction
- Biomarkers for transporter-mediated drug-drug interactions
- Endocrine-exocrine interactions of the pancreas
- Genetics of type 2 diabetes, and gene diet interactions in regulation of lipid and glucose metabolism
- Gut microbiome, bacteria/host interaction during cancer development;
- Host-pathogen interaction and macrophage biology
- Immune-metabolism of host pathogen interaction and anti-cancer immune regulation
- In vitro activity of newer antimicrobial agents including interactions with other classes of antibiotics
- Lung-liver interactions (hepato-pulmonary syndrome)
- Mechanisms underlying drug-drug interactions
- Molecular events and Interactions between immunocompetent cells, inflammatory cells, epithelial cells in allergic inflammation and airways remodelling
- Regulatory interactions between iron/zinc homeostasis
-
intervention
- Behavioural intervention trials
- Clinical trials and systematic reviews, particularly of interventions in children
- Complex interventions
- Dietary intervention for cancer patients
- Evaluation of person-centred care interventions using controlled designs
- Low intensity psychological interventions for common mental health conditions (Depression and anxiety) in Primary Mental Health Services
- Metabolomic and biomarker studies in relation to dietary interventions and cohort studies
- Non-pharma interventions in neurodevelopmental disorders
- Person-centred interventions
- Pharmacological interventions in neurodevelopmental disorders
- Psychosocial interventions
- Randomised controlled trials of complex interventions
- Remote delivery of interventions (telephone, computerised therapies) with Chronic Widespread Pain
- Sex-differential effects of interventions
- eHealth psychological interventions
-
liver
- Alcoholic liver disease
- Animal models of liver cancers and liver damage, and liver metastasis
- Biomarkers of response and toxicity to improve therapeutic ratio for liver cancer treatments
- Development of biomarkers and technologies for the non-invasive evaluation of disease progression in chronic liver diseases
- Drug-induced liver injury
- Early biomarkers of primary liver cancerHepatitis C and B
- Hepatology, liver disease
- Immunity (cytokine research) and chronic liver diseases
- Liver Fibrosis
- Liver Immunology
- Liver cell biology
- Liver cirrhosis and complications
- Liver disease
- Liver disease
- Liver disorders
- Liver proteins
- Liver regeneration
- Liver transplantation
- Mechanisms of insulin resistance, mitochondrial function and inflammation in obesity, diabetes mellitus and fatty liver diseases
- Non-alcoholic fatty liver disease and liver cancer in relation to the mechanisms and therapeutic targets;
- Non-alcoholic steatohepatitis and fatty liver
- Nonalcoholic fatty liver disease
-
lung
- Activation of dendritic cells and macrophages to bridge innate and adaptive immunity in the lung
- Advances in lung cancer screening
- Advances in radiotherapy of lung cancer
- Asbestos Exposure: Lung Function – Pathology – Small Airways Dysfunction
- Immune senescence and disregulation in relation to lung inflammation
- Interstitial lung diseases
- Lung cancer
- Lung cancer
- Lung cellular and molecular biology
- Lung function
- Lung function trajectories through the lifespan (trajectome)
- Lung infection
- Lung inflammation
- Lung inflammation and oncology
- Lung mechanics
- Lung physiology
- Mediators of inflammation, oxidative stress in lung disease
- Medical oncology with a special interest in lung cancer and breast cancer
- Molecular oncology with a special interest in lung cancer and breast cancer
- Pancreatic cancer, breast cancer, lung cancer, neuroendocrine tumors
- Pulmonary fibrosis and lung cancer
- Resistance mechanisms to targeted therapies in lung cancer
-
management
- Cardiovascular risk factors diagnosis and management
- Clinical management of Type 1 and Type 2 diabetes
- Health Care Management and chronic disease conditions
- Health crisis management
- Heart failure disease management
- Hepatopulmonary Syndrome (HPS): Definition – Diagnosis – Management – Pathophysiology
- Human resource management
- Investigation of the pathophysiology and management of both asthma and COPD
- Management of anti-thrombotics in gastrointestinal bleeding
- Management of neurological condition in resource-poor settings
- Rehabilitation and personalised management in COPD and chronic heart failure
-
mechanism
- Adults born preterm as a model to understand molecular and physiological mechanisms linking early life events with lifelong health
- Aldosterone and mineralocorticoid receptor-mediated mechanisms and the role of non-coding RNAs
- Cell and molecular mechanism of hepatic and intestinal fibrogenesis
- Drug resistance mechanisms
- Endometriosis - aetiology and inflammatory mechanisms
- Experimental and clinical investigations of the mechanisms of arrhythmias
- Immune mechanism of pancreatitis
- Impact and mechanisms of environmental pollution on the respiratory system
- Inflammatory mechanisms: transcriptional control of inflammatory genes, transcription factors, chromatin remodell
- Mechanism of inflammation in psoriasis
- Mechanisms and treatment of severe and difficult-to-treat asthma
- Mechanisms of corticosteroid resistance
- Mechanisms of disease
- Mechanisms of drug resistance in epilepsy
- Mechanisms of epileptogenesis
- Mechanisms of functional recovery after stroke in humans
- Mechanisms of insulin resistance, mitochondrial function and inflammation in obesity, diabetes mellitus and fatty liver diseases
- Mechanisms of invasion of the nervous system by neurotropic viruses
- Mechanisms underlying cerebral ischemia
- Mechanisms underlying cognitive-behaviour therapy
- Mechanisms underlying drug-drug interactions
- Mechanisms underlying functional recovery after stroke
- Metabolic syndrome – mechanisms and consequences
- Molecular mechanisms and developmental programming of sarcopenia in older people
- Molecular mechanisms and translational aspects of cardioprotection in the presence of co-morbidities
- Molecular mechanisms of atrial fibrillation
- Molecular mechanisms of inflammation
- Molecular toxicity mechanisms of drugs and pesticides, pharmacokinetics, metabolism, P450 isoforms, gene expression profiling
- Neurobiological mechanisms of psychosis
- Non-alcoholic fatty liver disease and liver cancer in relation to the mechanisms and therapeutic targets;
- Non-hemodynamic mechanism of the Renal-angiotensin system
- Resistance mechanisms to targeted therapies in lung cancer
- Resistant mechanism of antimicrobial agents
- Respiratory Pharmacology: molecular mechanisms of corticosteroids and bronchodilators
- Tumor immunological microenvironment and tumor immune evasion mechanisms
-
medical
- Cancer risk in patients with pancreatitis, cystic fibrosis, end-stage renal disease, hepatitic C virus infection of other medical conditions
- Development of positron emission tomography for medicine and medical research
- Medical Informatics
- Medical Psychology
- Medical Statistics
- Medical and veterinary entomology
- Medical biotechnology
- Medical consequences of climate changes
- Medical decision-making
- Medical device development for skin diseases
- Medical education
- Medical education
- Medical imaging
- Medical oncology with a special interest in lung cancer and breast cancer
- Medical psychology
- Medical statistics of child growth and development
- Secondary use of administrative and other real-world data in medical research
-
medicine
- Alternative medicine
- Aptamer-based translational medicine and drug discovery
- Bedside to bench approach - translational medicine
- Behavioral Medicine
- Behavioural medicine
- Big data in medicine
- Cardiovascular medicine
- Clinical chemistry, biochemistry and laboratory medicine
- Clinical laboratory diagnostics in veterinary medicine
- Clinical medicine
- Community medicine
- Conservation medicine
- Development of positron emission tomography for medicine and medical research
- Evidence-based medicine
- Evolutionary medicine
- Experimental medicine
- Experimental medicine
- Genetic medicine
- Genomic medicine
- Genomics and precision medicine
- Geriatric medicine
- High throughput diagnostics and preventative medicine
- History of medicine
- History of medicine and nursing
- Internal medicine
- Mass gatherings medicine
- Medicine
- Medicine
- Methodology for evaluating pharmacological action of medicines in man
- Methods for precision medicine
- Mitochondrial medicine
- Nephrology and internal medicine
- Nuclear medicine
- Nuclear medicine
- Pathogenesis and translational medicine of genitourinary tumors
- Pathophysiology and molecular medicine of autoimmunity and cancer
- Personalised medicine
- Personalised medicine
- Personalized medicine
- Physical medicine and rehabilitation
- Population medicine and public health
- Precision medicine
- Precision medicine
- Precision medicine for severe asthma
- Precision medicine in diabetes
- Predictive and prognostic biomarkers for personalized medicine
- Preventive medicine
- Rare lymphoma in human and veterinary medicine
- Relationship between the humanities and medicine
- Reproductive medicine
- Respiratory Medicine
- Respiratory Medicine: specifically asthma and chronic obstructive pulmonary disease
- Respiratory medicine
- Skeletal medicine
- Social history of medicine and public health
- Sports medicine
- Stratified medicine
- Systems medicine
- Systems medicine and network analysis
- Therapy development/experimental medicine
- Training image guided interventional medicine
- Translational medicine
- Translational medicine
- Vascular biology and medicine
-
mental
- Deep brain stimulation in mental disorders
- Involvement of service users and families in care planning in secondary care mental health services
- Low intensity psychological interventions for common mental health conditions (Depression and anxiety) in Primary Mental Health Services
- Mental diseases (posttraumatic stress syndrome)
- Mental health
- Mental health
- Mental health care
- Mental health trial design and analysis
- Perinatal mental illness
- Students’ mental health
- Transcranial magnetic stimulation in mental disorders
- Whole-body cryotherapy in mental disorders
-
metabolism
- Amino acid and nitrogen metabolism
- Bone and calcium metabolism
- Cancer metabolism
- Clinical-experimental research on the (patho)physiology of carbohydrate, lipid and amino acid metabolism
- Diet and metabolism
- Drug transporters and drug metabolism
- Genetics of type 2 diabetes, and gene diet interactions in regulation of lipid and glucose metabolism
- Glucose metabolism and glucose transporters
- Imaging of energy metabolism in focal ischemia
- Lipid metabolism and cardiovascular risk factors
- Lipoprotein metabolism
- Metabolism
- Metabolism
- Metabolism and inflammation
- Metabolism, hypometabolism, cryobiology and hibernation
- Mitochondrial metabolism
- Molecular toxicity mechanisms of drugs and pesticides, pharmacokinetics, metabolism, P450 isoforms, gene expression profiling
- NAD metabolism
- Oxidative metabolism in asthma and COPD
- Redox metabolism in melanoma and circulating tumor cells
- Serum lipoproteins metabolism
- Steroid metabolism
-
method
- Development of analytical methods for testing of drugs and xenobiotics.
- Epidemiological methods
- Epidemiological methods
- Epidemiological research methods
- Methods for precision medicine
- Mixed methods research
- Resampling methods to investigate model stability and model uncertainty
- Research Methods
-
methodology
- Diagnostic and Prognostic methodology
- Health survey methodology
- Instrumentation, methodology
- Meta-analysis methodology
- Methodology for evaluating pharmacological action of medicines in man
- Realist methodology
- Research methodology
- Research methodology
-
model
- Adults born preterm as a model to understand molecular and physiological mechanisms linking early life events with lifelong health
- Animal Models for AIDS
- Animal model
- Animal models
- Animal models of liver cancers and liver damage, and liver metastasis
- Biostatistics, survival analysis, meta-analysis, prognostic models
- Building and validation of multivariable regression models
- Comparative models across species
- Economical models on antimicrobial resistance
- Experimental animal models of infections (endocarditis, osteomyelitis)
- Experimental focal ischemia models
- Experimental models of neurological disorders (migraine, Parkinson's disease, Huntington's disease, mulitple sclerosis)
- Human infection models
- Investigation of newly synthesized kynurenic acid analogues in different animal models of neurological disorders
- Neurochemical investigations in models of neurological disorders (excitotoxins, peptides, kynurenines)
- Prognostic model development and validation
- Resampling methods to investigate model stability and model uncertainty
- Transgenic models of human disease
- Transgenic models of human disease
- Zebrafish model, mouse models, PDX, mevalonate pathway, CoQ10, therapy resistance
-
molecular
- Adults born preterm as a model to understand molecular and physiological mechanisms linking early life events with lifelong health
- Cell and molecular mechanism of hepatic and intestinal fibrogenesis
- Clinical and molecular immunology
- Clinical and molecular phenotyping of asthma
- Diseases associated to molecular defects of receptor function
- Human molecular genetics
- Lung cellular and molecular biology
- Molecular Biology technology
- Molecular allergology
- Molecular allergy diagnostics
- Molecular biology
- Molecular biology
- Molecular biology in cardiology
- Molecular biology of brain tumors
- Molecular biomarkers of migraine (CGRP, PACAP, kynurenines etc.)
- Molecular biomarkers of multiple sclerosis (catecohlamines, kynurenines, neurofilament etc.)
- Molecular cardiology
- Molecular events and Interactions between immunocompetent cells, inflammatory cells, epithelial cells in allergic inflammation and airways remodelling
- Molecular genetic analysis of multifactorial diseases/traits
- Molecular genetics
- Molecular genetics
- Molecular genetics and pathogenesis of neurodegenerative diseases
- Molecular imaging
- Molecular imaging
- Molecular mechanisms and developmental programming of sarcopenia in older people
- Molecular mechanisms and translational aspects of cardioprotection in the presence of co-morbidities
- Molecular mechanisms of atrial fibrillation
- Molecular mechanisms of inflammation
- Molecular neurobiology
- Molecular oncology
- Molecular oncology with a special interest in lung cancer and breast cancer
- Molecular pathogenesis and genetics of bone and soft tissue sarcomas
- Molecular pathogenesis of mycobacterial infections
- Molecular tools for bacterial epidemiology
- Molecular toxicity mechanisms of drugs and pesticides, pharmacokinetics, metabolism, P450 isoforms, gene expression profiling
- Molecular tumor pathology
- Molecular virology of hepatitis B, C and D
- Pathophysiology and molecular medicine of autoimmunity and cancer
- Respiratory Pharmacology: molecular mechanisms of corticosteroids and bronchodilators
- System biology based molecular characterization of atherosclerotic plaques and above cohorts.
-
neurological
- Clinical pharmacological studies in the field of neurological disorders
- Epidemiology of age-related neurological diseases
- Experimental models of neurological disorders (migraine, Parkinson's disease, Huntington's disease, mulitple sclerosis)
- Investigation of newly synthesized kynurenic acid analogues in different animal models of neurological disorders
- Kinase inhibitors in cancer, neurological and inflammatory disorders
- Management of neurological condition in resource-poor settings
- Neurochemical investigations in models of neurological disorders (excitotoxins, peptides, kynurenines)
- Neurological complication of systemic cancers
- Neurological conditions, epidemiology, outcomes
- Neurological diseases
- Neurological disorders
- Neurological disorders
-
neuroscience
- Addiction, physiopathology and neurosciences
- Basic neuroscience
- Clinical cognitive neuroscience in psychiatry
- Clinical neuroscience
- Clinical neurosciences
- Computational neuroscience
- Developmental neuroscience
- Neuroscience
- Neuroscience
- Translational neuroscience
- Visual neuroscience
-
new
- Clinical implementation of new imaging techniques
- Development of new more effective anti-seizure medications
- Identification of new risk factors: linked to diet, obesity and physical activity, occupational and lifestyle hazards
- In vitro activity of newer antimicrobial agents including interactions with other classes of antibiotics
- New (molecular) non-invasive imaging techniques (nanoMRI, PSMA-PET/CT)
- New antiallergic drugs and new strategies in the allergic disease treatment
- New combinatorial treatment approaches using immunotherapy for hepato-biliary pancreatic cancers
- New drugs
- New immunomodulators in COVID-19
- New psychoactive substance toxicity
- New techniques in interventional cardiology
- New theoretical developments in caring, 'humanisation of care', new theory existential wellbeing and its absence
- New therapeutic approaches for bacterial infections
- New therapies
- Novel approaches to new compounds to be used in animal food production
- PK/PDs of newer antimicrobial agents
- Public health, particularly new public health
-
nursing
- Community nursing
- Ethical leadership in nursing
- Evaluation of outcomes of nursing education
- Evaluation of the quality of nursing care
- Gerontological nursing
- History of medicine and nursing
- Nursing
- Nursing
- Nursing and care ethics
- Nursing leadership
- Nursing research
- Nursing research
- Research in clinical nursing/health care, consisting of analysis and instrumentation
- Research in health care and nursing ethics, consisting of
- Research in nursing/health care education/pedagogics, consisting of
-
obesity
- Childhood obesity
- Definition of child obesity based on body mass index
- Identification of new risk factors: linked to diet, obesity and physical activity, occupational and lifestyle hazards
- Mechanisms of insulin resistance, mitochondrial function and inflammation in obesity, diabetes mellitus and fatty liver diseases
- Obesity
- Obesity
- Obesity, diabetes, dyslipidemia and other metabolic abnormalities
- Pathophysiology of obesity
- Pre- and postnatal developmental influences on child obesity, allergic disorders and neurobehavioural outcomes
- Role of microbiota in obesity and type 2 diabetes
- Type 2 genomic/genetic diabetes and obesity (including microRNA and long non-coding RNA)
-
oncology
- Clinical oncology/hematology
- Cutaneous oncology
- Endocrine oncology
- Genitourinary oncology
- Hematology/oncology
- Lung inflammation and oncology
- Medical oncology with a special interest in lung cancer and breast cancer
- Molecular oncology
- Molecular oncology with a special interest in lung cancer and breast cancer
- Oncology
- Oncology
- Oncology: experimental and clinical
- Precision oncology
- Translational oncology
-
pancreatic
- Clinical and translational research in pancreatic cancer
- Clinical trials for pancreatic diseases
- Epidemiological analysis of pancreatic diseases (AP, CP, PC, AIP)
- Genetics of pancreatitis and pancreatic cancer
- New combinatorial treatment approaches using immunotherapy for hepato-biliary pancreatic cancers
- Pancreatic cancer
- Pancreatic cancer surveillance
- Pancreatic cancer, breast cancer, lung cancer, neuroendocrine tumors
- Pancreatic cysts
- Pancreatic ductal adenocarcinoma, adjuvant, neoadjuvant, chemotherapy, necrosectomy, pancreatectomy, PRSS1, SPINK1, hENT1, endoscopic sphincterotomy.
- Pancreatic physiology
- Pancreatic surgery
- Pathophysiology, cell biology and genetics of pancreatic disorders
- Screening and surveillance of pancreatic cancer
-
pathogenesis
- Epidemiology and pathogenesis of atherosclerosis and cardiovascular disease
- Inflammatory arthritis pathogenesis
- Inflammatory bowel diseases and pathogenesis
- Molecular genetics and pathogenesis of neurodegenerative diseases
- Molecular pathogenesis and genetics of bone and soft tissue sarcomas
- Molecular pathogenesis of mycobacterial infections
- Multi-omics for better understanding pathogenesis of IBD
- Pathogenesis and immunogenetics of invasive fungal infections
- Pathogenesis and therapy of Lyme Borreliosis
- Pathogenesis and translational medicine of genitourinary tumors
- Pathogenesis of atherosclerosis
- Pathogenesis of eosinophilic diseases
- Pathogenesis of infectious diseases
- Pathogenesis of inflammatory skin diseases
- Sleep apnea syndrome: pathogenesis and treatment
-
pathophysiology
- Atherosclerosis pathophysiology
- Heart failure pathophysiology
- Hepatopulmonary Syndrome (HPS): Definition – Diagnosis – Management – Pathophysiology
- Investigation of the pathophysiology and management of both asthma and COPD
- Pathophysiology
- Pathophysiology and molecular medicine of autoimmunity and cancer
- Pathophysiology and treatment of peripartum cardiomyopathy
- Pathophysiology and treatment options of heart failure
- Pathophysiology of COPD
- Pathophysiology of obesity
- Pathophysiology of thrombosis and cardiovascular diseases
- Pathophysiology, cell biology and genetics of pancreatic disorders
- Physiology and pathophysiology of cardiac arrhythmias
- Physiology and pathophysiology of pancreas
- Skin physiology and pathophysiology
- The physiology and pathophysiology of drug efflux transporters
-
patient
- Analysis of the realisation of patients' rights
- Cancer risk in patients with pancreatitis, cystic fibrosis, end-stage renal disease, hepatitic C virus infection of other medical conditions
- Dietary intervention for cancer patients
- Empowering patient education
- Genetic polymorphisms as markers for resistance, to select driver genes and provide personalized therapy of patients
- Health care research based on patient cohorts and epidemiologic registers
- Infections immunocompromised hosts, including neutropenic cancer patients
- Infections in critically ill patients
- Infections in immunocompromised patients
- Nurse staffing and patient safety and quality of care
- Patient and public involvement
- Patient and public involvement in research
- Patient reported outcomes
- Patients Reported Outcomes & Quality of life evaluation in patients with respiratory and allergic diseases
- Patients' perspectives and self-management
- Patients' rights
- Public and patient involvement
- Risk calculators for individual patients
-
pharmacology
- Airway pharmacology
- Antifungal pharmacology and drug development
- Bioinformatic pharmacology
- Cardiovascular pharmacology
- Clinical pharmacology
- Clinical pharmacology
- Clinical pharmacology and clinical trials
- Epilepsy, treatment, pharmacology, surgery
- Experimental behavioral pharmacology
- Pediatric clinical pharmacology
- Pharmacology
- Pharmacology
- Pharmacology and pharmacotherapy
- Pharmacology of cardiovascular system
- Respiratory Pharmacology: molecular mechanisms of corticosteroids and bronchodilators
- Systems pharmacology
- Transcriptomic-based network pharmacology
- Translation of preclinical pharmacology of anticancer agents to the clinic to achieve personalized therapy
-
physiology
- Adipocyte physiology
- Circulation Physiology
- Clinical-experimental research on the (patho)physiology of carbohydrate, lipid and amino acid metabolism
- Lung physiology
- Muscle physiology and diseases
- Pancreatic physiology
- Physiology and neuroprotection of the newborn
- Physiology and pathophysiology of cardiac arrhythmias
- Physiology and pathophysiology of pancreas
- Skin physiology and pathophysiology
- The physiology and pathophysiology of drug efflux transporters
-
prevention
- Asthma Outbreaks by Soybean Dust Inhalation: Diagnosis – Pathognesis – Prevention
- Cancer epidemiology and cancer prevention
- Cancer prevention
- Cardiac rehabilitation and secondary prevention
- Cardiovascular disease prevention
- Cardiovascular disease prevention
- Disease prevention
- HIV/AIDS prevention and treatment
- Heart failure prevention
- Hypertension and cardiovascular prevention
- Injury prevention and control
- Prevention and treatment of hypertension, hyperlipidemia, congestive heart failure and diabetes
- Prevention of epilepsy after brain injury
- Prevention of type 2 diabetes by changing lifestyles
- Prevention research
- Screening/prevention with imaging
- Vascular prevention
-
psychiatry
- Biological Psychiatry
- Child & adolescent psychiatry
- Clinical cognitive neuroscience in psychiatry
- Computational psychiatry
- Consultation-liaison psychiatry (psychiatry in somatic medicine)
- Neuromodulation in psychiatry
- Nutrition and psychiatry
- Old age psychiatry
- Psychiatry
- Psychiatry
- Psychiatry risk and resilience, in particular for schizophrenia
- Social psychiatry
-
public
- Epidemiology and public health aspects of chronic hepatitis B, C and D
- Global public health
- Patient and public involvement
- Patient and public involvement in research
- Population medicine and public health
- Public Health Specialist
- Public and patient involvement
- Public engagement in science
- Public health
- Public health
- Public health measures to reduce COVID-19 transmission, especially in young people
- Public health, particularly new public health
- Social history of medicine and public health
-
pulmonary
- Chronic Obstructive Pulmonay Disease (COPD): Guidelines – Exacerbations – Physical Activity – Gas Exchange – Pulmonary Vascular Changes
- Chronic obstructive pulmonary disease
- Chronic obstructive pulmonary disease
- Chronic obstructive pulmonary diseases
- Idiopathic pulmonary fibrosis (IPF)
- Immunopathology of pulmonary arterial hypertension
- Pulmonary Hypertension
- Pulmonary embolism
- Pulmonary fibrosis
- Pulmonary fibrosis and lung cancer
- Pulmonary heart disease
- Pulmonary hypertension
- Pulmonary nodules
- Pulmonary vascular disease
- Pulmonary vein isolation
- Respiratory Medicine: specifically asthma and chronic obstructive pulmonary disease
-
receptor
- Affinity of cardiac receptors for various drugs
- Diseases associated to molecular defects of receptor function
- Gonadotropin receptors
- Growth factor receptors and antibodies
- IgG and IgG receptors
- Immune receptors
- Inhibitory receptors on cancer cells as target for therapy
- Mast cell and eosinophil activating and inhibitory receptors
- Natural Killer Cell Receptors
- Nuclear receptors
- Peptide receptor radionuclide therapy
- Quantitative evaluation of cardiac and CNS receptors with PET
- Sex steroid receptors
- TSH receptor
- Thyroid hormone receptors
-
research
- (Nutritional) biomarker research, including omics data
- Applied health research
- Applied health research
- Basic, translational and clinical research in chronic airway diseases (COPD, asthma)
- Biostatistics, specifically prediction research
- Cancer research
- Cancer research
- Cancer research (primarily psychosocial, symptom, secondary prevention)
- Clinical and translational research in acute pancreatitis
- Clinical and translational research in chronic pancreatitis
- Clinical and translational research in pancreatic cancer
- Clinical cancer research
- Clinical drug research
- Clinical research
- Clinical research, translational research
- Clinical-experimental research on the (patho)physiology of carbohydrate, lipid and amino acid metabolism
- Computational imaging research
- Critical creative research
- Development of positron emission tomography for medicine and medical research
- End-of-life research
- Epidemiological ageing research
- Epidemiological research methods
- European research
- Health care research based on patient cohorts and epidemiologic registers
- Health services research
- Implementation research
- Interdisciplinary research
- Interdisciplinary research with humanities
- Melanoma research
- Mixed methods research
- National health and biomedical sciences research strategy
- Neurospin facility for neuroimaging research
- Nursing research
- Nursing research
- Organisation of Clinical Research
- Outcomes research
- Participatory and Action research
- Patient and public involvement in research
- Pedagogical research
- Physical therapy research
- Preclinical and clinical research in obstructive airway diseases (Asthma and Chronic Obstructive Pulmonary Disease)
- Prevention research
- Regulatory and ethical aspects of clinical research
- Research Methods
- Research administration
- Research assessment
- Research ethics
- Research impact
- Research in clinical nursing/health care, consisting of analysis and instrumentation
- Research in health care and nursing ethics, consisting of
- Research in nursing/health care education/pedagogics, consisting of
- Research infrastructure
- Research integrity and conflicts of interest
- Research integrity and research quality
- Research methodology
- Research methodology
- Research strategy and organization
- Research synthesis
- Secondary use of administrative and other real-world data in medical research
- Sexual lifestyle research
- Skin cancer research and treatment
- Sleep research
- Translational and basic research
- Translational research
- Translational research
- “Real life” research on adherence/inertia to cardiovascular treatments
-
resistance
- Antibiotic resistance, including epidemiology, phenotypic and genotypic detection
- Antimicrobial resistance
- Antimicrobial resistance
- Cancer drug resistance
- Drug resistance mechanisms
- Economical models on antimicrobial resistance
- Genetic polymorphisms as markers for resistance, to select driver genes and provide personalized therapy of patients
- Insulin resistance
- Mechanisms of corticosteroid resistance
- Mechanisms of drug resistance in epilepsy
- Mechanisms of insulin resistance, mitochondrial function and inflammation in obesity, diabetes mellitus and fatty liver diseases
- One health antimicrobial resistance
- Paradigm-shifting studies on the role of ectopic fat stores and nutrient-induced insulin resistance in humans
- Resistance mechanisms to targeted therapies in lung cancer
- Resistance surveillance studies at national level
- Resistance to anti-signalling drugs
- Resistance to classical chemotherapeutics
- Therapy resistance
- Treatment resistance
- Zebrafish model, mouse models, PDX, mevalonate pathway, CoQ10, therapy resistance
-
respiratory
- Acute respiratory distress syndrome
- Cystic fibrosis, particularly respiratory infections
- Emerging respiratory infectious diseases
- Genetic epidemiology of respiratory diseases
- Impact and mechanisms of environmental pollution on the respiratory system
- Inflammatory response to allergen inhalation or exacerbations by respiratory virus
- Patients Reported Outcomes & Quality of life evaluation in patients with respiratory and allergic diseases
- Respiratory Diseases
- Respiratory Medicine
- Respiratory Medicine: specifically asthma and chronic obstructive pulmonary disease
- Respiratory Pharmacology: molecular mechanisms of corticosteroids and bronchodilators
- Respiratory allergy
- Respiratory disease
- Respiratory failure
- Respiratory medicine
- Respiratory muscles
- Respiratory syncytial virus
- Respiratory tract infections
- Respiratory virus
- Respiratory virus infections
- Severe respiratory and food allergy
-
response
- Acute phase protein response in animals and their use in diagnostic analysis
- Biomarkers of response and toxicity to improve therapeutic ratio for liver cancer treatments
- Cellular stress responses
- Clinical and immunopharmacological activities of Biological Responses Modifiers
- Increased oncogene expression in response to myocardial overload and during restenosis
- Inflammatory response to allergen inhalation or exacerbations by respiratory virus
- Innate immune response to viral infections
- Innate immune responses
- Psychosocial response to major incidents
- Response shift (i.e., shifts in patients' perspectives over time)
-
risk
- Atherosclerosis related disease biomarkers discovery, risk prediction and clinical testing
- Cancer risk in patients with pancreatitis, cystic fibrosis, end-stage renal disease, hepatitic C virus infection of other medical conditions
- Cardiovascular risk factors and diseases
- Cardiovascular risk factors diagnosis and management
- Diet and cancer risk
- Diet and diabetes risk
- Endogenous hormones and cancer risk
- Environmental risk assessment
- Identification of new risk factors: linked to diet, obesity and physical activity, occupational and lifestyle hazards
- Lipid metabolism and cardiovascular risk factors
- Modifiable risk factors
- Psychiatry risk and resilience, in particular for schizophrenia
- Real life risk simulation of exposure
- Risk assessments evaluation to animals, humans and environment
- Risk calculators for individual patients
- Risk prediction
- Risk stratification
- Risk stratification by metabotyping
-
science
- Basic and translational cardiovascular sciences
- Dermatology and cutaneous science
- Diagnostic sciences
- Food Science
- Implementation science
- Implementation science in health
- Laboratory Sciences
- National health and biomedical sciences research strategy
- Pharmaceutical sciences
- Polymer science
- Popularization of Science
- Population data science
- Public engagement in science
- Stem cell science
-
skin
- Autoimmune diseases of the skin & psoriasis
- Inflammatory skin disease
- Inherited skin disease
- Inherited skin disease
- Innate immune cells in the skin
- Keratinizing skin disorders
- Medical device development for skin diseases
- Pathogenesis of inflammatory skin diseases
- Skin ageing
- Skin cancer research and treatment
- Skin physiology and pathophysiology
- Stem cell therapy for severe skin fragility syndromes
-
stem
- Hematopoietic stem cells
- Hemopoietic stem cell transplantation
- Stem cell biology
- Stem cell science
- Stem cell therapy for severe skin fragility syndromes
- Stem cell transplantation
- Stem cells
- Stem cells in cardiology
-
stroke
- Acute stroke care
- Acute treatment of stroke
- Cerebral hemodynamics in stroke-risk diseases and stroke
- Cerebrovascular diseases and stroke
- Clinical neurology, with special regard to stroke
- Description of a 4-hour therapeutic window in acute ischaemic stroke in man
- First therapeutic trials in the hyper-acute phase of ischaemic stroke in man
- Ischemic and hemorrhagic stroke
- Ischemic stroke
- Mechanisms of functional recovery after stroke in humans
- Mechanisms underlying functional recovery after stroke
- Neurorehabilitation of stroke
- Postdoctoral Education Stroke rehabilitation Post stroke depression’
- Stroke
- Stroke
-
study
- Anthropology and admixture/outbreeding studies
- Biomarker studies
- Clinical epidemiological studies
- Clinical pharmacological studies in the field of neurological disorders
- Clinical studies and trials in major rheumatic diseases
- Cohort Studies
- Developmental studies using longitudinal approaches
- Genome-wide association studies
- Guidance for planning and analysis of observational studies - The STRATOS initiative
- Large-scale genetic studies of asthma
- Longitudinal cohort studies
- Mechanistic studies of cellular immune-dysregulation in systemic lupus erythematosus
- Metabolomic and biomarker studies in relation to dietary interventions and cohort studies
- Neural circulatory studies in sleep and sleep apnea
- Paradigm-shifting studies on the role of ectopic fat stores and nutrient-induced insulin resistance in humans
- Pharmacological and toxicological in vivo and in vitro studies with drugs, pesticides, and chemicals and their interpretation.
- Population-based (cohort) studies
- Population-based cohort studies
- Resistance surveillance studies at national level
- Running of several clinical and autopsy cohort studies (TVS, TSDS, YFS-3G, FINCAVAS)
- Studies of antioxidant vitamins and alcohol intake
- Treatment and outcome studies in rheumatoid arthritis, systemic lupus erythematosus and spondyloarthritis
- Twin and family studies
-
syndrome
- Acute coronary syndromes
- Acute respiratory distress syndrome
- Arrhythmias and acute coronary syndromes
- Chronic fatigue syndrome
- Delineation of cough hypersensitivity syndrome
- Hepatopulmonary Syndrome (HPS): Definition – Diagnosis – Management – Pathophysiology
- Hyper-IgD syndrome
- Locked-in syndrome
- Metabolic syndrome – mechanisms and consequences
- Multi-inflammatory syndrome in children (MISC, SARS-CoV-2-associated)
- Paraneoplastic syndromes
- Polycystic ovary syndrome
- Sleep apnea syndrome: pathogenesis and treatment
- Stem cell therapy for severe skin fragility syndromes
-
systemic
- Cognitive impairment in systemic disease and multimorbidity
- Genetic and environmental imbalances of iron homeostasis in systemic disorders
- Mechanistic studies of cellular immune-dysregulation in systemic lupus erythematosus
- Neurological complication of systemic cancers
- Systemic Lupus Erythematosus
- Systemic lupus erythematosus (SLE) is a systemic autoimmune disease
- Systemic treatment of germ cell cancer
- Systemic treatment of prostate cancer
- Systemic treatment of renal cell cancer
- Systemic treatment of urothelial cancer
- Treatment and outcome studies in rheumatoid arthritis, systemic lupus erythematosus and spondyloarthritis
-
target
- Cancer target identification
- Development of macromolecular and nano systems for targeting and reducing toxicity of drugs
- Enzyme targeting, gene transfer
- Epigenetics (methylation, acetylationb, miRNA) as marker and targets for cancer therapy
- Inhibitory receptors on cancer cells as target for therapy
- Non-alcoholic fatty liver disease and liver cancer in relation to the mechanisms and therapeutic targets;
- Pharmacogenetics of anticancer drugs (both conventional chemotherapy and "targeted" drugs
- Target therapy
- Targeted therapy
- Targeted therapy and drug delivery in cancer
- Targets for targeted (biological) therapies
-
therapeutic
- Biomarkers of response and toxicity to improve therapeutic ratio for liver cancer treatments
- Cancer therapeutics
- Description of a 4-hour therapeutic window in acute ischaemic stroke in man
- Development of prophylactic and therapeutic approaches
- First therapeutic trials in the hyper-acute phase of ischaemic stroke in man
- Investigational therapeutic agents for cancer
- Microbiome diagnostics and therapeutics
- New therapeutic approaches for bacterial infections
- Non-alcoholic fatty liver disease and liver cancer in relation to the mechanisms and therapeutic targets;
- Normal and pathological erythropoiesis and therapeutic implications
- Personalised therapeutics
- Signal pathways of oxidative stress, apoptosis, inflammation, and DNA methylation and drug therapeutic effect.
- Therapeutic approach of infections caused by Multi-drug/Extremely-drug/Pan-drug resistant gram negative bacteria
- Therapeutic proteins
- Therapeutics of Immune Mediated Inflammatory Diseases (IMID)
-
therapy
- Anticoagulant therapy
- Anticoagulation and antithrombotic therapy
- Antimicrobial therapy of invasive candidiasis, aspergillosis
- Antiviral therapy of chronic hepatitis
- Biologic therapy
- Boron neutron capture therapy
- Cancer therapy
- Cancer therapy
- Clinical interests and expertise: Breast cancer diagnosis, prognosis and therapy
- Clinical pioneer of successful substrate reduction therapy in sphingolipid diseases
- Dyslipidemia therapy
- Engineered cell therapy for cancers
- Epigenetics (methylation, acetylationb, miRNA) as marker and targets for cancer therapy
- Gene and cell therapy
- Genetic polymorphisms as markers for resistance, to select driver genes and provide personalized therapy of patients
- Immunosuppressive therapy
- Inhibitory receptors on cancer cells as target for therapy
- Innovative Therapies (targeted therapies for pulmonary hypertension)
- Innovative Therapies (targeted therapies for severe asthma)
- Mechanisms underlying cognitive-behaviour therapy
- New therapies
- Non-invasive image guided therapies
- Novel cancer therapies
- Pathogenesis and therapy of Lyme Borreliosis
- Peptide receptor radionuclide therapy
- Physical therapy research
- Predictive biomarkers for targeted therapies in solid tumours
- Psychological therapies
- Radionuclide therapy
- Resistance mechanisms to targeted therapies in lung cancer
- Stem cell therapy for severe skin fragility syndromes
- Target therapy
- Targeted therapy
- Targeted therapy and drug delivery in cancer
- Targets for targeted (biological) therapies
- Therapy development/experimental medicine
- Therapy resistance
- Translation of preclinical pharmacology of anticancer agents to the clinic to achieve personalized therapy
- Tumor immune therapy
- Zebrafish model, mouse models, PDX, mevalonate pathway, CoQ10, therapy resistance
-
thyroid
- Enterohepatic circulation of thyroid hormones
- Thyroid endocrinology
- Thyroid hormone receptors
- Thyroid hormones
-
translational
- Aptamer-based translational medicine and drug discovery
- Basic and translational cardiovascular sciences
- Basic, translational and clinical research in chronic airway diseases (COPD, asthma)
- Bedside to bench approach - translational medicine
- Clinical and translational research in acute pancreatitis
- Clinical and translational research in chronic pancreatitis
- Clinical and translational research in pancreatic cancer
- Clinical research, translational research
- Molecular mechanisms and translational aspects of cardioprotection in the presence of co-morbidities
- Pathogenesis and translational medicine of genitourinary tumors
- Post translational modificications
- Translational and basic research
- Translational medicine
- Translational medicine
- Translational neurophysiological biomarker
- Translational neuroscience
- Translational oncology
- Translational research
- Translational research
-
treatment
- Acute treatment of stroke
- Advanced endoscopic imaging and treatment
- Antimicrobial stewardship and treatment of complicated bacterial and fungal infections
- Autoimmune diseases and treatment (immunosuppression)
- Biologics in Severe Asthma Treatment
- Biomarkers for early detection and treatment of GI cancer.
- Biomarkers of response and toxicity to improve therapeutic ratio for liver cancer treatments
- COVID-19 treatment trials
- Diabetes treatment
- Diagnosis and treatment of esophageal and gastric cancer
- Epilepsy, treatment, pharmacology, surgery
- Focus on asthma phenotypes, biomarkers and novel treatments including applications of biologics
- HIV/AIDS prevention and treatment
- IPF diagnosis and treatment guidelines
- Immune treatment of hematological disorders
- Invasive treatments in hypertension
- Mechanisms and treatment of severe and difficult-to-treat asthma
- New antiallergic drugs and new strategies in the allergic disease treatment
- New combinatorial treatment approaches using immunotherapy for hepato-biliary pancreatic cancers
- Non-pharmacological treatment of heart failure
- Novel treatments for neonatal seizures and their long-term sequelae
- Pathophysiology and treatment of peripartum cardiomyopathy
- Pathophysiology and treatment options of heart failure
- Prevention and treatment of hypertension, hyperlipidemia, congestive heart failure and diabetes
- Skin cancer research and treatment
- Sleep apnea syndrome: pathogenesis and treatment
- Systemic treatment of germ cell cancer
- Systemic treatment of prostate cancer
- Systemic treatment of renal cell cancer
- Systemic treatment of urothelial cancer
- Testosterone treatment
- Treatment and outcome studies in rheumatoid arthritis, systemic lupus erythematosus and spondyloarthritis
- Treatment of mitochondrial diseases
- Treatment resistance
- “Real life” research on adherence/inertia to cardiovascular treatments
-
trial
- Behavioural intervention trials
- COV-AID trial addressing the impact of early interleukin-1 and -6 blockade in COVID-19
- COVID-19 treatment trials
- COVID-19 vaccine clinical trials
- Cancer clinical trials
- Clinical pharmacology and clinical trials
- Clinical studies and trials in major rheumatic diseases
- Clinical trial design
- Clinical trials
- Clinical trials
- Clinical trials and systematic reviews, particularly of interventions in children
- Clinical trials development
- Clinical trials for pancreatic diseases
- Clinical trials in hypertension and other cardiovascular diseases
- Early clinical trials in solid tumours
- Early phase clinical trials
- First therapeutic trials in the hyper-acute phase of ischaemic stroke in man
- Highlow randomized controlled trials
- Mental health trial design and analysis
- Novel drugs and Clinical Trials
- Observational clinical trials in acute pancreatitis (APPLE, PINEAPPLE, EASY, LIFESPAN)
- Phase I trials across solid tumors
- Practice-changing multicenter trials
- Randomised clinical trials
- Randomised controlled trials
- Randomised controlled trials of complex interventions
- Randomized control trials
- Randomized interventional clinical trials in acute pancreatitis (GOULASH, PREPAST, EMILY)
- Randomized trials
- Statistics and clinical trials
- Use of next generation sequencing to measure residual disease (leukemic cells) in clinical trials
-
tumor
- Adrenal disorders and tumors
- Brain tumor and brain function protection
- Brainstem tumor
- Chemotherapy of brain tumors
- Dendritic cell subsets and regulatory T cells in the tumor microenvironment
- Gastrointesitnal stromal tumors GIST
- Induction of tumor cell senescence by the immune system
- Metastatic brain tumors
- Molecular biology of brain tumors
- Molecular tumor pathology
- National Brain Tumor Registry of China
- Pancreatic cancer, breast cancer, lung cancer, neuroendocrine tumors
- Pathogenesis and translational medicine of genitourinary tumors
- Phase I trials across solid tumors
- Redox metabolism in melanoma and circulating tumor cells
- Skull-base tumor
- Special interest in tumor immunology
- Transcriptional signaling involved in the development and progression of tumors
- Tumor
- Tumor associated angiogenesis
- Tumor biology
- Tumor heterogeneity and plasticity
- Tumor immune surveillance
- Tumor immune therapy
- Tumor immunity
- Tumor immunological microenvironment and tumor immune evasion mechanisms
- Tumor immunology
- Tumor immunotherapy
- Tumor microenvironment
- Tumor vaccine: exosomes, dendritic cells
-
use
- Acute phase protein response in animals and their use in diagnostic analysis
- Development of biochemical assays for use in veterinary laboratories
- Developmental studies using longitudinal approaches
- Evaluation of person-centred care interventions using controlled designs
- Human brain changes throughout the lifespan using magnetic resonance imaging and fetal ultrasound
- New combinatorial treatment approaches using immunotherapy for hepato-biliary pancreatic cancers
- Novel approaches to new compounds to be used in animal food production
- Secondary use of administrative and other real-world data in medical research
- Short and long-term consequences of ketamine use
- Substance use
- Use of next generation sequencing to measure residual disease (leukemic cells) in clinical trials
-
vascular
- Autoimmune, inflammatory, infectious, and vascular disease conditions
- Chronic Obstructive Pulmonay Disease (COPD): Guidelines – Exacerbations – Physical Activity – Gas Exchange – Pulmonary Vascular Changes
- Extra- and intracranial ultrasound in vascular diseases
- Hypertension-mediated vascular injury
- Pulmonary vascular disease
- Vascular aging and longevity
- Vascular biology
- Vascular biology
- Vascular biology and medicine
- Vascular brain lesions on MRI
- Vascular disease
- Vascular imaging
- Vascular prevention
- Vascular remodelling
-
other
- 3-D printing of implants
- ADHD
- ADME
- Abdominal aortic aneurysm
- Acromegaly and gigantism
- Adaptive behaviors
- Adaptive changes in myocardial contractility
- Adaptive immunity
- Affordable diagnostics
- Age assessment of unaccompanied asylum seeking children
- Ageing
- Aging
- Air Pollution - ozone, PM2.5, NO2
- Alcohol
- Aldosterone
- Allergology
- Allergology
- Allergy
- Allergy
- Ambulatory/Home blood pressure monitoring
- Anaesthesia
- Andrology
- Angiomatoid fibrous histiocytoma (EWSR1-CREB1/ATF1)
- Antibiotic Stewardship
- Antibiotic consumption
- Antibiotic stewardship
- Anticoagulants and antidotes
- Antioxidants
- Antitrypsin and the serpinopathies
- Apoptosis regulation
- Arrhythmia
- Arterial mechanical properties
- Arteriosclerosis
- Artificial intelligence
- Asia - Pacific
- Atherosclerosis
- Atopic dermatitis
- Atopic dermatitis
- Atopic eczema
- Atrial fibrillation
- Autism
- Autoantibodies
- Autoimmunity
- Autoimmunity
- Autonomous nervous system
- Autophagy
- B-cells
- BRICS
- Back pain
- Bacterial pneumonia
- Barrett's oesophagus
- Bioactive Compounds
- Biobanking
- Biochemistry
- Biodegradable materials
- Biological foundations of Adaptive Behavior
- Biomarker
- Biomaterials
- Biomechanics
- Biomedical engineering
- Biometry
- Biostatistics
- Biostatistics
- Blood coagulation
- Blood pressure variability
- Body composition
- Bone growth
- Bone strength
- Brainstem glioma
- Bronchial provocation
- Butyrophilin (BTN)
- COVID
- CPR
- CT-imaging
- Calcium handling and signaling
- Campylobacters
- Cancer-related distress
- Cannabinoids, adolescence and addiction
- Cardioncology
- Cardioprotection
- Cardioprotection
- Carer
- Catheter ablation
- Cellular electrophysiology
- Cellular signaling
- Cerebral amyloid angiopathy
- Chemistry
- Cholangiocarcinoma
- Cholangiocarcinoma pathology
- Cholangiocarcioma
- Circadian rhythms
- Classification of idiopathic interstitial pneumonia's
- Climate change and renewable energy
- Cloned unique translocation inEwing-like sarcoma (NFATC2)
- Cluster headache
- Co-morbidities
- Co-morbidities of IMID
- Co-receptors
- Cognitive theories of depression
- Colon carcinogenesis
- Coma
- Computed tomography
- Computer processing of biosignals
- Congenital diaphragmatic hernia
- Conjugate chemistry
- Consciousness
- Construction of growth charts
- Contraception
- Coronary blood flow
- Coronary microcirculation
- Coronary microembolization
- Coronavirus vaccines
- Corticosteroid hormones
- Cortisol and the HPA axis
- Crossroads in atherosclerosis and osteoporosis
- Cytochrome P450
- Cytokines
- Cytokines (macrophage migration inhibitory factor)
- Cytoskeleton, microtubule-associated protein tau
- Cytoskeleton/structural molecules
- DNA methylation
- DNA repair
- Declining fertility rates
- Deep sequencing DNA/RNA
- Degenerative dementias (particularly familial disease)
- Dementia
- Dementia
- Depression
- Dermatology
- Dermatology
- Dermatopharmacology
- Diabetic nephropathy
- Diabetology
- Diagnostics
- Diagnostics
- Diaphragmatic neural small fibers
- Dietary assessment
- Digital phenotyping
- Discovered causative somatic genetic background in Chondromyxoid fibroma (GRM1)
- Doctoral training
- Duchenne muscular dystrophy
- Dyslipidemias
- Early life trauma
- Echocardiograpy
- Editing, editorial process, publishing, writing
- Educator, postgraduate teaching
- Electrocardiography
- Electrophysiology
- Electroporation
- Emerging markets
- End of life
- Endocrine programming
- Endocrine regulation of fluid and elecrolyte homeostasis
- Endoscopy (interventional)
- Environment
- Epigenetic inheritance of acquired traits; noncoding RNAs and methylomics
- Epigenetic processes that "hold" the memory of developmental programming
- Epigenetics
- Epigenomics
- Epilepsy
- Epilepsy and migraine headache
- Epithelial ion transports of the gastrointestinal tract
- Erectile dysfunction
- Estimation of growth curves
- Ethics
- Ethics of leadership
- European academic leadership
- Evidence based practice
- Evidence based practice
- Evidence-based healthcare
- Evidence-based surgery
- Excimer laser for psoriasis and vitiligo
- Exercise and training
- Exotoxicology (hormonal effects of microplastic compounds)
- Extra Virgin Olive Oil
- Extracellular Matrix
- Falls
- Familial hypercholesterolemia
- Fatigue
- Fecal microbiota transplantation
- Female and male infertility
- Female fertility
- Female reproductive hormones
- Fetal programming
- Fibrin and fibrinolysis
- Fibrinolytics in parapneumonic pleural effusions
- Fibrosis
- Filaggrin
- Flavonoids
- Food allergy
- Food safety
- Foregut anomalies
- Fracture repair
- Functional forms of continuous variables, emphasize on Multivariable Fractional Polynomials
- Functional urology
- GI-tract
- Gastric carcinogenesis
- Gastroenterology
- Gastrointestinal pathology
- Gastrointestinal stromal tumour
- General cognitive functioning
- Generalized structural equation modeling
- Genetic archaeology
- Genetic contributions to the aetiology of epilepsy
- Genetic counceling/prenatal diagnostics
- Genetic discovery
- Genetic susceptibility of H. pylori
- Genetic testing for common mutations
- Genomics
- Genomics
- Glioblastoma
- Glioma, IDH mutant
- Glucocerebrosidase
- Glucocorticoids
- Growth signaling
- Gut microbiota
- Gut-brain axis
- HIV and mucosal transmission
- HLA
- Haemostasis
- Health-economics
- Healthcare humanities
- Healthy ageing
- Healthy ageing
- Healthy longevity
- Helicobacter pylori
- Hemato-oncology
- Hematology
- Hepatic encephalopathy
- Hepatitis C and B
- Hepatobiliary surgery
- Hepatobiliary transport
- Hepatocellular carcinoma
- Hepatocellular carcinoma pathology
- Hepatotoxicity
- Hereditary and acquired thrombophilia
- Hibernating myocardium
- Hidradenitis suppurativa
- Hip/Knee/Ankle
- Histone modifications
- History of neurology
- Hormones
- Humoral immunity
- Hyperaldosteronism
- Hypertrophic cardiomyopathy
- Imaging
- Immunity
- Immuno-epidemiology
- Immuno-oncology
- Immunological memory
- Immunopharmacology
- Implant biomechanics
- In vitro fertilisation
- Inborn errors of immunity
- Indoor microbes
- Infertility
- Inflammatory conditions
- Influenza vaccines
- Inherited and acquired thrombophilia
- Innovations in gastrointestinal endoscopy
- Insulin-like growth factors/receptors
- Interdisciplinary collaboration
- Intermediate phenotypes
- Interventional endoscopy
- Intestinal microbiota
- Intracerebral hemorrhage
- Investigation of genetic susceptibility of the pancreas
- Ischemia
- Ischemic conditioning
- Keratins
- LILR
- Lead poisoning
- Left ventricular healing and remodelling
- Lentiviral vectors
- Lifestyle
- Lifestyles and nutrition
- Lipid mediators
- Lipids
- Lipoprotein(a)
- Low-middle income country microbiology
- Lymphoma pathology
- Lyssavirus
- MERS
- MHC
- Machine Learning
- Machine learning
- Macrophages
- Macrophages in tissue repair
- Magnetic surgery
- Major Histocompatibility Complex
- Major depression
- Malaria
- Male contraception
- Male infertility
- Male infertility
- Male senesce
- Mass spectrometry and metabolomics
- Mechanical ventilation
- Medication safety (oncology, geriatrics)
- Mediterranean diet
- Membrane proteins
- Mendelian Randomization
- Mercury poisoning
- Mesenteric ischemia
- Meta-analyses of continuous variables
- Metabolic dysfunction
- Methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Enterobacteriaceae
- Microbiome
- Microbiome
- Microsatellite DNA instability
- Migraine
- Mitochondria
- Moisture damage in buildings
- Moral courage and ethical competence of professionals
- Multi-morbidity
- Multi-omics
- Multimodal neuroimaging
- Multiple endocrine neoplasia
- Multiple sclerosis
- Musculoskeletal
- Musculoskeletal modeling
- Myeloma
- Myocardial ischemia
- NASH
- NK
- Nanomedicine
- Nanomedicine, nanotoxicology
- Natural history of hepatitis B, C and D
- Natural history of hepatitis B, C and D
- Natural immunity
- Neonatal sepsis
- Neonatology
- Nephrology
- Neural reinforcement learning
- Neuro-ophthalmology
- Neurobiological basis of behavioral differences and vulnerabilities
- Neurobiology
- Neurodegeneration
- Neurodegeneration
- Neurodevelopment
- Neuroendocrine neoplasms
- Neuroendocrinology
- Neuroendocrinology
- Neuroepidemiology
- Neuroepidemiology
- Neurohumoral alterations
- Neuroimaging
- Neuroimaging
- Neuroinflammation
- Neurology
- Neurology
- Neuromodulation
- Neurophysiology
- Neuroplasticity
- Neuroprotection
- Neuropsychiatry
- Neuropsychopharmacology
- Neurostimulation
- Neurosurgery
- Neurotraumatology
- Non-coding RNA
- Non-competitive active targeting strategies
- Non-genetic inheritance
- Noninvasive tracing of metabolic fluxes
- Nutrition
- Nutrition
- Objective assessment and training of communication skills
- Objective assessment and training of robotic of surgical skills
- Objective assessment of surgical skills
- Older people
- Oncogenes
- One-human-animal-environmental-ecosystems-health (one-health)
- Ophthalmology
- Organ damage
- Organ preservation
- Organisation of healthcare
- Organoprotection
- Orthopaedic biomechanics
- Orthopaedic surgery
- Orthopaedics
- Osteoarthritis
- Osteoblastoma (del chrom 22)
- Osteonecrosis
- Osteoporosis
- Osteoporosis
- Osteosarcoma (SMAD and GLI-mediated pathways, del P16 and stem cell tumourigenesis)
- Outdoor air pollution
- Ovulation induction
- Paediatrics
- Paediatrics
- Pain and nociception
- Palliation of strictures in the GI tract
- Pancreatitis
- Pandemic preparedness and COVID-19
- Paracetamol (acetaminophen) poisoning
- Participation in ca. 40 different ongoing international consortiums and EU funded projects
- Pathology
- Patient-reported outcome measures
- Pediatrics
- Person-centred cultures
- Person-centred outcome measurement
- Pharmaceutical technology
- Pharmacoeconomics
- Pharmacoepidemiology
- Pharmacogenetics
- Pharmacogenetics
- Pharmacogenetics and pharmacogenomics
- Pharmacogenomics
- Pharmacogenomics
- Pharmacokinetics and pharmacodynamics
- Pharmacokinetics/toxicokinetics
- Pharmacovigilance
- Phenotyping of COPD: particular interest in multi- and comorbidity in COPD
- Photodermatology
- Phylodynamics
- Phylogenetics
- Physical activity
- Physiological and functional neuroimaging
- Physiotherapy
- Platelets
- Pollutant toxicity
- Pollution
- Polyphenols
- Population ageing
- Positron emission tomography
- Postnatal adaptation
- Precancerous conditions
- Precision-polyesters for ligand-receptor stoichiometry optimization
- Preconception nutrition and lifestyle
- Premature ovarian insufficiency
- Prenatal stress
- Primary healthcare
- Primary healthcare
- Professional competence of students.
- Prognostic and predictive markers
- Progressive supranulear palsy
- Psoriasis
- Psoriasis
- Psychedelics, cannabinoids and ketamine
- Psycho-oncology
- Psycho-oncology
- Psychological measurements
- Psychological resources, resilience, self-efficacy
- Psychometrics
- Psychometrics
- Psychopharmacology
- Psychosocial stress
- Psychotherapy
- Qualitative and quantitative measurements of CBF and CMRO2 in man
- Qualitative phenotypic change in the overloaded myocardium
- Quality of life
- Rabies virus
- Radiation protection
- Radiofrequency
- Radiopharmaceuticals
- Radiotherapy
- Reconstructive urology
- Reflexivity
- Regeneration
- Regenerative Hepatology and tissue engineering
- Regenerative engineering
- Rehabilitation
- Renal fibrosis
- Reperfusion
- Reporting guidelines, structured reporting and reviews of the literature
- Reproducibility
- Reproductive aging
- Responsive delivery systems
- Rheumatoid Arthritis Vaccine(s)
- Rheumatoid arthritis
- Rheumatology
- Rheumatology/Arthritis
- SARS-CoV-2
- Sarcoma
- Sarcopenia
- Schizophrenia
- Scientific literacy in younger people
- Self-management
- Self-regulation
- Sensory neurons
- Sepsis
- Septic shock
- Sequencing technologies
- Sex steroid biosynthesis
- Sex-differences
- Shock
- Simulation based training
- Sleep
- Smoking
- Social Innovation
- Social anthropology
- Social support
- Somatosensation
- Spatial ecology
- Spermatogenesis
- Statistical Literacy
- Statistics
- Statistics and demography
- Stress
- Stressful events
- Structured reporting
- Stunned myocardium
- Subarachnoid hemorrhage
- Suicide
- Suicide and self harm
- Suicide and self harm
- Surgery, including minimally invasive
- Surgical neuro-oncology
- Sustainability
- Symptoms
- Synthetic lethality
- Systematic review
- T Iymphocytes
- T-cells
- TB/HIV co-infections
- TRIM21
- Technological educational solutions
- The Mast Cell-Eosinophil Allergic Effector Unit
- The role of microbiome in acne
- Theranostics
- Thrombin
- Thrombin generation
- Thrombosis
- Thrombosis
- Thrombotic manifestations of atherosclerosis
- Timing and intensity of puberty
- Tissue engineering
- Tissue repair and fibrosis
- Tobacco
- Tomato
- Toxicology
- Translationale und grundlagenbasierte Forschung
- Transplant
- Transplant
- Transplantation
- Transplantation immunity
- Trauma and memory
- Tuberculosis
- Tumorigenesis in upper and lower GI-tract
- Tumour microenvironment
- Ulcerative colitis
- University administration
- University governance
- Urology
- Urology
- Uterine leiomyoma
- Vaccination
- Vaccinology
- Vaccinology
- Value-based healthcare
- Venous thromboembolism
- Ventilation distributon
- Ventricular tachycardia/fibrillation
- Vesicoureteral reflux
- Viral evolution and adaptation
- Virology
- Virtual reality simulation
- Virus associated malignancy
- Vision
- Vitamin A supplementation
- Wine
- Women’s issues in thrombosis and haemostasis
- Workforce policy and planning
- Zoonotic coronaviruses
- mRNA optimization
- mRNA vaccine
- mRNA vaccines
